rfhg_101591.1

Basic information about the TSS

---

TSS ID: rfhg_101591.1 Species: human Chr: chr7		Start: 143382020 End: 143382047 Strand: +
Source datasets	FANTOM5|EPD
Protocol	CAGE|TSS_database
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4041910,EH38E2598134)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000477373.1:0 GeneID: 7791 HGNC/MGI_ID: HGNC:13200 UniProt_ID: Nearer transcript ids and distances: AK299005:-10 ENST00000392910.6:-113 U15158:230 BC021069:335 AK302309:-413 ENST00000354434.8:-445 AK298925:-445 CR457431:-448 CU679075:-449 KJ892433:-449 DQ892925:-450 DQ896174:-450 AB590188:-451 X94991:-458 view more...

Gene_name: zyxin Gene_symbol: ZYX Gene_synonyms: Gene_source: HGNC:13200

TATA-Box annotation

---

Distance to TSS:	271
Nearest PromoterID:	NM_001371250
Entrez ID:
Nearest Unigene:
Nearest Refseq:
Nearest Ensembl:
Gene Name:	zyxin
Gene Alias:
Gene Type:
CpG%:	0.148148
GC%:	0.607143
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZYX p2@ZYX p3@ZYX p5@ZYX p6@ZYX p9@ZYX
Sample		p1@ZYX	p2@ZYX	p3@ZYX	p5@ZYX	p6@ZYX	p9@ZYX
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	95.26	1.75	1.36	0.00	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	102.78	1.62	1.21	0.20	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	88.35	2.51	1.35	0.58	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	66.53	1.66	2.49	0.42	0.62	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	67.49	2.02	0.67	0.22	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	63.38	2.52	0.58	0.39	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	77.78	1.31	1.09	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	69.03	1.45	0.73	0.00	0.73	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	77.37	1.07	1.07	0.21	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	57.96	1.16	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	51.34	2.02	0.81	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	50.41	1.22	0.81	0.00	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	206.33	3.71	2.58	0.97	1.45	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	160.42	3.76	4.36	1.05	3.01	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	177.40	2.63	3.07	1.10	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	171.52	6.04	4.78	0.75	2.01	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	162.28	4.37	1.53	1.53	1.97	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	169.99	6.33	1.69	1.69	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	131.69	4.80	2.67	0.53	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	173.91	3.01	3.61	0.30	1.65	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	187.25	3.61	2.81	0.80	1.07	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	194.20	4.14	2.93	0.35	1.55	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	168.94	4.01	3.36	1.03	1.55	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	174.72	4.61	2.67	0.24	0.73	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	200.20	4.13	2.84	1.03	1.03	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	184.53	2.85	3.48	1.27	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	175.28	6.59	4.40	0.55	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	251.31	4.95	2.59	0.47	2.83	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	197.06	3.07	2.42	1.13	2.58	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	194.72	4.16	3.26	0.90	2.35	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	173.96	3.98	3.56	0.84	2.09	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	172.72	3.13	3.13	1.56	1.37	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	206.18	4.22	3.80	0.84	1.48	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	183.74	7.09	2.97	0.99	3.79	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	195.59	3.74	4.11	0.75	3.74	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	199.48	4.79	3.64	1.72	1.53	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	208.26	3.07	4.70	0.20	2.86	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	218.81	5.84	1.81	1.01	3.83	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	201.23	5.67	3.78	0.81	1.89	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	204.53	3.60	3.12	1.20	2.40	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	209.62	3.53	4.47	2.12	1.65	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	189.29	4.68	2.93	0.44	2.20	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	210.47	3.37	4.01	1.48	1.90	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	234.44	5.77	3.50	0.35	1.92	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	205.59	4.62	4.62	1.41	2.01	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	213.80	6.51	6.05	1.40	1.16	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	216.64	4.08	5.52	0.48	2.40	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	223.84	4.47	4.47	0.60	2.09	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	220.46	3.11	4.55	1.44	2.39	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	215.95	6.47	3.03	0.81	1.82	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	215.00	7.79	5.74	0.41	2.66	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	272.41	5.78	4.45	0.44	3.56	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	244.14	6.74	5.68	0.35	0.71	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	219.38	5.30	4.64	0.66	2.65	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	244.13	17.62	3.36	0.84	7.55	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	182.78	8.27	8.27	0.00	3.67	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	237.57	6.81	5.83	0.32	2.92	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	269.14	6.10	4.18	0.32	1.93	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	173.20	6.29	5.03	0.31	5.66	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	300.35	6.35	1.41	0.71	1.41	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	289.93	5.61	4.49	1.12	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	290.59	18.31	7.96	2.39	12.74	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	218.47	8.49	5.44	1.02	2.72	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	313.22	7.47	8.45	1.62	2.60	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	320.90	6.74	11.00	2.13	1.77	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	0.00	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	284.31	39.49	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	255.95	6.34	3.41	0.98	1.46	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	204.30	3.47	5.45	0.50	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	204.06	2.35	2.35	0.47	1.88	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	106.64	0.66	2.65	0.66	2.65	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	135.49	2.47	1.86	0.31	0.62	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	162.66	2.14	1.22	0.31	1.53	1.83
Adipocyte - breast, donor1	11376-118A8	370.30	11.72	5.70	1.58	4.75	2.69
Adipocyte - breast, donor2	11327-117E4	315.56	6.90	14.28	1.93	3.85	2.09
Adipocyte - omental, donor1	11473-119C6	365.40	10.18	6.11	0.76	3.18	2.67
Adipocyte - omental, donor2	11474-119C7	313.20	3.74	8.97	0.00	2.99	0.00
Adipocyte - omental, donor3	11475-119C8	285.02	9.38	10.38	0.33	4.02	2.34
Adipocyte - perirenal, donor1	11476-119C9	261.58	5.74	4.47	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	285.87	11.00	4.40	2.20	3.30	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	325.17	6.77	4.06	1.81	0.90	3.16
Adipocyte - subcutaneous, donor3	11408-118E4	455.12	8.86	8.86	2.26	7.99	3.30
Adipocyte differentiation, day04, donor1	13019-139D4	233.51	4.11	0.98	0.78	2.93	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	171.41	3.35	0.51	0.26	2.06	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	198.76	4.18	1.12	0.00	2.51	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	184.57	4.11	1.18	0.59	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	113.49	1.69	1.13	0.80	1.37	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	150.40	2.58	0.32	0.00	1.29	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	129.03	3.20	4.80	1.07	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	85.69	1.67	0.56	0.00	2.23	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	84.84	1.25	2.08	1.25	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	126.09	2.26	1.00	1.76	1.51	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	133.84	3.60	1.96	1.31	1.96	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	86.17	0.61	0.61	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	666.75	2.21	3.76	3.98	0.44	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	655.13	1.79	10.76	3.94	1.79	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	330.65	1.20	3.59	0.00	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	343.62	0.54	1.80	1.62	0.00	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	291.19	0.00	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	438.84	2.67	5.14	1.85	2.88	0.82
Anulus Pulposus Cell, donor1	11248-116E6	498.78	2.98	3.55	3.66	1.26	0.92
Anulus Pulposus Cell, donor2	11463-119B5	517.24	2.94	5.63	4.16	2.94	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	296.98	5.84	4.04	2.25	3.15	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	363.81	6.51	6.08	0.00	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	199.04	2.14	4.28	0.00	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	317.16	5.68	5.08	0.60	3.59	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	295.93	8.85	10.12	0.00	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	211.88	2.64	2.64	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	285.25	4.87	4.87	1.62	2.92	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	317.48	3.88	6.31	0.00	1.94	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	229.83	4.75	6.53	0.59	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	302.82	6.40	6.03	0.75	2.26	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	333.81	2.90	2.18	0.00	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	199.35	2.51	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	329.97	1.15	1.15	0.66	0.66	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	271.60	4.09	5.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	151.39	1.36	1.06	0.30	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	325.22	0.00	3.75	1.61	4.29	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	304.75	3.02	3.40	0.94	1.32	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	275.84	2.41	5.61	1.07	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	292.64	6.83	1.95	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	309.99	2.32	2.65	0.66	1.66	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	195.72	0.00	6.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	307.99	0.00	7.08	7.08	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	347.69	3.95	3.43	0.69	1.89	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	155.21	0.00	8.39	0.00	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	316.50	4.85	5.34	0.97	3.88	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	360.10	2.66	4.93	0.00	2.28	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	228.95	6.06	8.48	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	302.69	3.99	1.71	0.00	2.85	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	300.35	1.28	2.99	1.07	2.99	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	251.90	3.61	2.58	0.52	1.81	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	312.49	3.75	3.75	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	302.90	4.18	3.22	0.64	1.61	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	191.92	2.85	2.14	2.85	1.43	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	323.48	2.34	3.51	0.58	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	285.72	2.71	4.52	0.60	1.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	222.15	7.13	4.75	2.38	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	316.32	5.59	7.63	1.53	2.54	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	300.02	2.04	4.08	1.78	2.04	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	184.26	3.81	3.81	1.27	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	306.39	5.18	5.18	0.00	3.02	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	279.00	3.18	4.02	1.06	2.96	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	212.85	2.03	4.64	0.58	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	333.49	4.72	5.67	1.89	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	291.24	2.54	4.92	0.34	0.85	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	275.65	4.63	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	297.87	8.45	6.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	304.68	2.79	3.86	0.64	1.50	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	232.24	4.81	4.81	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	260.97	2.92	5.10	0.00	2.92	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	337.01	4.37	3.45	2.07	1.84	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	275.43	2.55	2.55	0.00	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	122.29	0.76	0.76	0.51	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	322.66	2.89	4.34	0.83	1.45	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	253.67	1.53	2.75	1.84	0.92	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	310.23	4.78	5.74	0.48	2.87	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	291.14	3.55	4.66	1.55	1.55	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	209.03	0.00	1.53	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	250.36	2.22	0.55	1.11	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	278.30	2.38	2.91	1.06	2.12	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	211.89	4.72	2.91	0.36	1.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	463.63	1.60	2.21	0.98	0.61	0.12
Astrocyte - cerebellum, donor2	11580-120F5	559.01	3.42	8.04	3.77	2.05	0.86
Astrocyte - cerebellum, donor3	11661-122F5	426.21	1.05	4.19	0.42	0.63	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	225.88	0.35	0.35	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	291.52	2.10	4.21	0.81	1.94	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	358.73	2.39	4.03	1.04	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	177.99	2.98	4.13	0.69	1.72	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	188.92	2.00	2.76	1.13	1.63	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	170.35	2.39	2.96	0.46	0.91	0.23
Basophils, donor1	12241-129G9	485.14	4.97	1.57	1.31	1.57	0.52
Basophils, donor2	12242-129H1	321.11	2.53	1.08	0.36	0.36	0.36
Basophils, donor3	12243-129H2	513.02	2.65	1.76	2.06	1.03	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	276.40	1.51	1.29	0.86	0.86	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	719.15	3.20	11.89	4.57	2.29	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	129.12	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	466.97	2.51	6.90	3.77	3.14	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	502.62	6.65	9.57	3.12	2.08	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	287.40	6.91	6.91	0.69	0.69	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	127.04	0.90	2.52	0.00	0.72	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	6.39	0.00	0.10	0.10	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	21.43	0.23	0.23	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	172.04	0.32	0.32	0.64	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	310.26	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	428.87	1.69	0.56	0.56	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	502.05	4.45	9.28	1.30	2.78	2.04
CD14+ Monocytes, donor3	11381-118B4	446.54	6.15	2.63	0.66	1.10	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	297.76	7.36	2.26	0.28	4.81	3.96
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	256.63	7.20	2.65	0.38	3.79	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	384.30	10.85	4.27	1.64	4.60	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	665.94	13.88	18.07	3.61	6.65	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	496.07	9.35	11.77	1.51	4.83	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	593.18	11.37	10.90	2.61	4.26	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	535.17	12.05	9.88	2.34	3.52	3.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	465.63	10.76	7.73	1.93	2.21	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	511.23	5.21	9.17	3.47	2.73	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	539.43	8.42	10.38	4.70	2.94	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	449.57	4.27	7.48	2.14	4.45	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	403.27	5.44	3.92	1.31	1.09	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	338.08	8.90	5.15	0.70	1.64	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	351.67	10.03	4.22	0.53	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	323.93	2.22	1.11	0.00	1.11	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	561.38	11.75	13.24	3.42	5.65	3.27
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	472.53	8.98	16.36	2.99	3.59	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	326.66	5.00	3.96	0.83	1.46	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	527.58	7.55	13.96	2.52	5.72	2.97
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	444.26	3.85	3.39	1.36	0.45	3.62
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	340.00	4.36	5.24	0.87	1.31	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	439.26	5.11	6.72	1.34	3.23	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	483.60	9.94	11.51	1.74	4.71	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	466.27	5.05	5.47	2.10	2.95	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	442.74	6.80	8.82	2.76	3.49	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	426.95	3.87	6.69	1.76	2.11	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	370.28	2.63	10.97	1.75	3.07	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	523.30	9.42	10.99	3.66	2.44	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	467.57	5.95	10.78	3.72	1.49	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	502.23	8.62	9.27	2.37	1.72	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	341.10	4.09	5.73	2.46	2.05	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	332.63	2.78	2.55	0.93	0.93	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	201.83	1.86	2.09	0.46	0.46	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	378.60	3.49	3.49	2.18	1.96	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	386.92	3.23	2.31	1.39	2.31	2.08
CD14+CD16+ Monocytes, donor3	11912-125G4	302.40	1.08	1.30	0.87	1.52	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	742.17	3.27	6.85	3.58	2.34	3.89
CD14+CD16- Monocytes, donor2	11799-124C8	500.36	4.54	3.67	1.22	1.75	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	956.76	9.36	5.80	1.34	2.90	3.12
CD14-CD16+ Monocytes, donor1	11790-124B8	348.06	2.04	0.26	4.08	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	346.03	4.61	2.85	1.10	2.20	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	372.88	3.37	1.05	1.05	1.05	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	37.97	0.00	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	19.68	1.04	0.00	0.00	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	45.84	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	35.92	0.00	0.54	1.07	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	43.52	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	50.98	0.00	0.78	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	44.38	0.82	0.00	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	57.31	0.00	2.18	0.00	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	47.45	1.01	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	42.43	0.00	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	25.97	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	107.43	0.00	0.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	155.06	1.69	0.56	0.56	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	127.01	0.38	0.00	0.38	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	141.83	0.00	0.23	0.45	0.68	0.23
CD4+ T Cells, donor1	11225-116C1	239.94	1.43	0.00	0.71	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	243.11	1.84	5.51	0.61	3.06	1.22
CD4+ T Cells, donor3	11382-118B5	251.92	3.05	5.79	0.91	1.83	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	135.02	1.28	0.51	0.26	0.77	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	124.43	1.80	1.35	0.67	0.90	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	137.41	1.44	0.86	0.29	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	100.03	0.95	0.95	0.95	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	120.10	2.11	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	141.74	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	209.69	4.91	3.32	0.87	2.02	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	205.39	2.71	2.54	0.51	2.03	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	185.71	3.39	1.13	0.64	0.48	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	171.70	2.24	1.34	0.90	0.45	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	183.43	1.75	0.35	1.05	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	283.35	2.64	2.64	1.32	0.88	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	170.34	1.69	1.26	0.42	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	143.57	2.91	0.83	0.21	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	143.34	1.34	0.33	0.67	1.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	172.95	1.90	1.63	0.82	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	150.60	1.61	1.61	1.07	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	199.05	7.17	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	314.12	2.60	2.23	1.11	1.67	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	197.34	2.60	1.95	0.65	1.73	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	289.80	2.73	2.94	0.00	1.05	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	104.15	0.51	0.00	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	136.04	1.30	0.00	0.43	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	172.58	2.18	3.92	0.87	0.87	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	217.25	1.98	3.46	0.99	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	167.10	0.92	1.85	0.00	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	131.21	2.79	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	358.35	3.05	2.49	1.94	3.05	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	368.09	2.70	2.70	0.25	1.72	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	210.98	0.00	1.54	0.00	1.54	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	294.73	1.79	1.43	2.15	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	171.74	2.77	0.00	1.38	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	203.97	1.96	0.33	0.00	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	212.12	2.63	3.38	0.38	2.63	1.50
CD8+ T Cells, donor3	11383-118B6	228.00	3.28	3.53	0.50	1.51	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	95.43	1.61	0.92	0.00	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	87.23	0.00	1.20	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	82.62	2.19	1.09	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	81.06	0.00	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	105.83	0.96	0.72	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	102.10	0.68	1.82	0.00	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	54.54	0.00	0.87	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	61.06	0.53	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	65.20	1.41	0.23	0.00	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	57.05	0.00	0.60	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	52.00	0.58	0.87	0.29	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	61.55	0.80	0.27	0.00	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	65.66	0.44	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	57.38	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	47.74	0.75	0.00	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	129.30	0.72	2.52	0.36	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	115.66	1.15	3.16	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	109.60	0.71	0.94	0.00	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	75.74	0.63	0.32	0.32	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	67.05	0.31	0.31	0.00	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	70.21	0.64	0.64	0.00	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	58.13	0.00	1.91	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	53.99	0.79	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	47.65	1.51	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	54.60	0.00	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	76.24	1.40	0.70	0.00	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	89.16	0.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	371.03	3.66	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	297.44	1.98	2.96	0.49	1.98	0.99
Cardiac Myocyte, donor3	11686-122I3	365.79	0.53	1.16	0.42	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	244.05	3.81	6.24	1.39	3.12	2.08
Chondrocyte - de diff, donor2	11338-117F6	321.62	6.40	1.42	0.00	1.07	1.42
Chondrocyte - de diff, donor3	11410-118E6	202.30	3.30	3.53	0.68	2.50	0.57
Chondrocyte - re diff, donor2	11339-117F7	86.84	1.79	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	136.28	1.21	0.40	0.40	2.02	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	375.60	2.18	3.44	1.95	0.69	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	434.80	4.70	6.84	1.92	1.92	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	475.50	4.16	3.72	2.57	2.74	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	349.65	3.03	3.94	2.11	2.48	0.37
Corneal Epithelial Cells, donor1	11526-119I5	301.47	1.76	0.88	0.22	1.10	0.88
Corneal Epithelial Cells, donor2	11606-120I4	142.20	1.14	5.69	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	235.44	0.77	2.05	0.77	0.26	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	296.68	2.15	0.66	1.49	1.16	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	287.34	1.58	1.26	0.95	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	196.69	0.00	0.00	0.00	3.45	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	313.71	4.32	4.64	3.02	1.73	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	183.12	0.34	1.02	1.37	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	127.96	0.65	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	125.34	1.45	0.00	0.48	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	643.56	5.67	2.67	1.33	2.17	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	443.60	8.21	2.93	0.00	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	719.72	5.09	4.24	0.57	1.13	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	486.37	3.54	0.79	1.97	3.15	0.39
Endothelial Cells - Artery, donor1	11264-116G4	591.64	5.24	8.14	1.75	5.82	0.87
Endothelial Cells - Artery, donor2	11341-117F9	880.88	12.94	16.47	5.41	7.53	2.12
Endothelial Cells - Artery, donor3	11413-118E9	688.79	7.36	11.75	2.63	4.56	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	324.94	2.88	2.22	4.43	1.33	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	394.63	3.04	2.13	3.96	1.83	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	367.60	3.38	1.97	0.85	2.26	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	527.71	6.24	5.65	1.19	4.46	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	349.37	5.21	3.12	0.00	1.04	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	428.91	5.67	6.10	0.99	3.12	1.56
Endothelial Cells - Thoracic, donor1	11266-116G6	490.55	4.00	2.80	1.20	3.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	720.67	3.67	9.96	5.77	3.67	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	442.57	4.85	4.47	2.61	0.99	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	335.02	5.21	1.52	2.17	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	395.69	3.91	1.10	2.56	1.59	0.49
Endothelial Cells - Vein, donor1	11267-116G7	702.98	1.14	14.79	2.28	5.69	0.00
Endothelial Cells - Vein, donor2	11344-117G3	776.73	7.68	6.29	1.40	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	446.37	3.45	4.71	2.83	1.73	0.79
Eosinophils, donor1	12244-129H3	228.70	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1090.82	13.20	0.00	4.95	3.30	0.00
Eosinophils, donor3	12246-129H5	1155.65	0.00	21.40	3.57	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	332.53	1.47	1.22	1.22	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	316.19	2.08	8.32	4.16	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	357.91	16.27	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	380.96	5.75	3.69	2.87	3.69	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	172.77	12.37	4.49	0.55	3.61	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	275.83	9.21	7.91	1.52	3.79	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	458.68	17.22	12.61	2.67	5.70	2.43
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	260.52	1.91	2.32	1.23	0.82	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	448.88	22.36	16.77	2.32	5.06	2.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	180.23	5.80	3.16	1.05	4.74	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	406.28	11.63	12.29	5.32	6.31	1.99
Fibroblast - Cardiac, donor1	11268-116G8	505.79	5.44	6.35	1.36	2.72	0.91
Fibroblast - Cardiac, donor2	11345-117G4	829.95	12.13	3.79	0.76	0.76	2.27
Fibroblast - Cardiac, donor3	11417-118F4	493.34	5.68	8.99	0.63	5.05	0.79
Fibroblast - Cardiac, donor4	11452-119A3	314.32	3.03	0.91	0.61	1.52	0.61
Fibroblast - Cardiac, donor5	11456-119A7	309.14	4.44	4.57	4.19	2.41	1.14
Fibroblast - Cardiac, donor6	11460-119B2	270.60	2.43	4.09	1.36	1.21	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	479.15	3.35	3.62	1.21	1.07	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	268.78	2.16	3.45	0.43	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	408.68	1.46	2.93	2.93	2.93	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	689.38	2.77	2.08	11.07	1.15	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	419.60	2.54	3.39	1.19	1.53	1.36
Fibroblast - Dermal, donor1	11269-116G9	387.39	7.28	5.87	2.35	5.63	2.58
Fibroblast - Dermal, donor2	11346-117G5	605.64	4.72	2.83	2.36	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	544.83	8.34	8.34	6.17	5.44	1.57
Fibroblast - Dermal, donor4	11450-119A1	276.40	3.17	5.43	3.73	1.81	0.90
Fibroblast - Dermal, donor5	11454-119A5	330.94	3.31	5.06	5.41	1.40	1.05
Fibroblast - Dermal, donor6	11458-119A9	368.70	3.41	6.01	4.39	1.14	0.49
Fibroblast - Gingival, donor1	11237-116D4	355.66	3.33	2.08	3.12	1.04	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	582.16	19.65	12.05	1.57	4.19	5.24
Fibroblast - Gingival, donor2	11318-117D4	391.53	3.16	7.38	10.41	1.98	1.05
Fibroblast - Gingival, donor3	11394-118C8	344.30	7.25	5.70	2.03	2.22	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	401.01	22.86	4.16	2.08	3.12	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	419.89	13.22	12.33	1.06	5.11	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	528.96	3.90	4.52	3.43	2.65	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	447.33	7.44	6.90	5.41	3.38	2.57
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	3439.16	64.22	26.82	62.11	32.82	7.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	516.68	7.46	7.75	5.26	3.66	2.63
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	384.11	8.73	6.27	1.50	2.59	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	652.24	10.20	10.09	7.35	4.50	2.08
Fibroblast - Gingival, donor9 (control)	11927-125I1	322.24	16.73	9.39	1.17	7.34	2.93
Fibroblast - Lung, donor1	11270-116H1	776.19	6.80	17.67	9.52	4.08	1.36
Fibroblast - Lung, donor2	11347-117G6	349.16	1.49	4.48	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	524.64	4.22	6.33	3.59	3.38	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	1781.00	5.83	7.50	4.17	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	777.64	6.99	18.18	1.40	5.59	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	652.11	3.92	8.12	1.68	2.24	1.68
Fibroblast - Mammary, donor1	11540-120B1	1513.05	11.77	5.28	8.53	2.44	1.22
Fibroblast - Mammary, donor2	11620-122A9	938.64	11.98	11.98	15.98	7.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	1000.65	5.96	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	364.67	1.55	2.72	5.63	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	481.89	6.37	11.07	8.95	2.58	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	570.67	3.67	2.14	7.34	0.61	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	599.15	9.16	7.25	3.05	3.05	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	645.55	11.61	12.96	2.97	7.29	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	423.19	12.76	6.15	1.51	5.10	2.32
Fibroblast - Pulmonary Artery, donor1	11250-116E8	449.43	1.22	2.43	3.09	1.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1683.03	7.92	7.52	21.13	1.42	2.64
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	626.77	7.35	6.01	12.03	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	395.76	2.37	3.95	2.37	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	266.12	1.39	2.98	1.19	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	330.01	3.20	3.37	1.24	0.71	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	430.43	2.17	3.94	2.37	2.17	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	250.31	1.81	3.61	1.50	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	486.54	6.15	4.53	1.40	4.32	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	351.77	2.28	5.06	1.27	2.02	0.76
Fibroblast - skin normal, donor1	11553-120C5	422.17	3.61	3.94	0.66	1.31	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	303.37	1.40	1.20	0.60	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	468.66	6.13	6.43	1.21	3.62	1.41
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	348.48	1.81	3.02	1.21	1.51	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	392.61	3.81	3.73	1.16	1.16	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	381.90	5.47	5.64	2.39	4.10	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	299.86	3.94	3.94	0.99	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	416.07	5.65	4.15	1.60	3.30	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	570.65	3.37	3.88	1.69	1.18	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	267.22	6.27	4.55	0.47	5.65	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	509.68	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	55.78	1.74	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	244.09	3.64	1.91	0.52	1.21	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	347.42	2.86	3.64	3.12	1.82	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	361.29	8.18	2.81	2.30	1.53	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	256.46	7.66	5.36	0.77	1.53	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	216.31	10.21	6.38	0.64	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	157.47	4.85	1.43	0.29	2.00	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	189.17	8.27	4.41	1.10	4.69	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	119.19	7.53	0.46	0.46	1.60	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	187.43	6.93	1.98	0.59	3.76	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	170.23	13.22	3.70	0.53	7.67	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	102.74	5.22	1.63	0.00	1.63	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	156.99	3.98	1.77	0.44	2.21	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	219.90	1.41	2.40	0.57	3.53	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	250.10	2.22	2.71	0.99	2.34	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	229.41	2.15	3.76	1.34	4.03	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	503.88	5.20	6.69	3.10	3.84	2.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	570.73	5.54	9.27	3.18	4.71	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	413.92	6.30	6.91	4.47	3.46	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	299.60	3.65	2.51	2.05	2.28	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	375.57	4.86	4.98	3.36	3.99	1.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	474.75	4.15	6.56	2.40	5.68	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	219.84	3.84	2.95	0.59	3.55	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	253.86	3.66	3.66	1.91	1.75	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	312.34	6.26	4.24	1.79	4.02	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	200.22	2.62	3.02	1.01	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	201.70	2.71	3.73	0.85	1.87	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	339.79	3.19	2.66	1.33	2.39	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	322.99	3.23	4.16	1.14	3.12	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	283.83	3.07	1.71	0.85	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	161.55	2.32	1.33	0.33	1.88	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	202.42	1.25	0.83	1.16	1.58	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	197.03	1.63	1.02	0.82	0.82	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	183.82	1.24	2.48	0.00	1.44	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	169.02	2.19	2.19	0.58	1.50	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	152.09	2.33	1.67	0.83	1.33	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	164.44	1.10	1.54	1.76	1.54	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	162.23	2.71	1.35	0.25	2.95	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	149.77	2.11	1.30	0.65	1.13	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	173.19	1.92	2.57	0.64	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	144.88	2.75	1.71	0.95	1.23	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	146.15	2.21	1.27	0.79	1.11	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	149.31	3.04	1.82	0.00	1.22	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	138.30	1.46	1.67	1.46	2.09	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	121.19	0.22	1.98	0.22	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	117.27	1.68	0.84	0.84	1.12	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	170.45	2.69	3.15	0.74	1.30	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	138.78	1.87	2.67	0.53	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	190.03	1.38	2.60	1.22	1.22	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	204.41	2.20	2.33	1.04	1.55	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	124.15	1.90	0.81	0.54	1.63	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	216.80	1.29	3.32	1.66	1.84	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	222.60	3.51	2.19	1.32	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	262.81	4.96	0.00	0.99	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	364.61	3.03	4.88	2.77	2.90	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	317.77	1.82	4.64	0.81	1.82	2.02
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	358.62	3.30	4.57	0.76	1.78	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	253.80	2.79	3.18	0.40	1.39	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	321.40	3.70	3.08	1.08	2.62	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	232.61	2.45	1.43	0.20	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	117.04	0.31	0.63	0.00	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	87.87	0.57	0.85	0.00	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	127.75	3.69	2.31	0.46	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	207.88	2.47	4.95	0.00	2.47	12.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	184.12	4.25	4.64	0.77	2.71	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	178.10	9.63	6.42	0.00	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	102.59	3.48	1.74	0.00	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	101.55	3.91	1.63	0.33	2.60	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	130.95	3.71	4.53	0.00	1.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	136.62	3.33	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	91.72	1.96	1.12	0.28	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	107.20	1.31	2.61	0.33	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	103.18	0.84	4.19	0.00	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	91.92	1.59	2.23	0.32	1.27	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	96.80	3.74	3.06	1.02	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	48.03	0.00	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	121.41	1.72	3.44	0.57	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	84.95	0.30	1.18	0.00	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	62.68	3.39	5.08	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	107.69	3.73	1.66	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	92.05	2.07	2.53	0.23	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	63.04	1.15	1.15	0.38	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	57.04	0.65	1.63	0.00	0.65	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	62.87	1.34	3.34	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	80.91	3.85	1.54	0.39	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	315.30	5.82	6.16	1.37	2.74	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	96.91	4.97	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	87.76	3.77	1.42	0.00	0.94	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	95.35	1.81	3.02	0.60	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	71.72	1.53	3.56	0.51	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	73.39	0.00	4.39	0.00	0.40	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	79.92	1.48	1.48	0.49	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	69.65	2.36	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	53.09	2.33	1.17	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	87.78	2.19	2.19	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	56.80	0.85	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	79.39	0.60	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	51.44	0.49	0.97	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	446.25	3.42	5.71	2.28	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	615.41	4.16	8.32	2.08	3.74	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	907.43	10.12	5.62	13.49	5.62	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	372.35	3.49	4.12	0.32	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	262.34	1.25	1.25	0.84	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	137.05	1.28	1.04	0.23	0.81	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	130.31	1.52	1.69	0.51	0.51	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	128.54	0.91	1.14	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	148.22	1.09	1.86	0.11	0.66	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	156.03	0.86	3.01	0.00	0.64	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	126.59	0.65	1.08	0.65	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	112.46	0.87	1.25	1.00	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	110.82	0.17	1.54	0.51	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	102.84	1.28	1.60	0.32	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	440.98	11.75	13.99	3.92	5.60	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	679.92	9.95	6.92	4.33	3.90	3.46
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	272.31	5.29	18.51	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	883.57	5.64	3.17	2.82	2.12	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	801.34	2.91	8.72	1.45	2.18	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	224.49	0.17	2.27	0.52	0.35	0.17
Hepatocyte, donor1	11523-119I2	56.90	0.00	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	173.45	4.31	4.31	0.00	2.15	3.23
Hepatocyte, donor3	11684-122I1	62.58	1.84	0.00	0.00	1.84	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.96	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	160.27	3.50	1.40	0.35	0.52	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	362.77	0.96	1.37	4.12	0.55	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	353.41	0.00	3.18	3.18	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	327.09	0.00	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	216.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	310.10	1.38	2.77	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	342.87	5.01	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	296.71	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	363.93	7.69	5.13	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	388.52	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	337.86	1.62	4.87	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	310.12	0.00	8.34	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	268.66	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	353.37	1.32	7.94	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	284.92	0.00	5.54	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	366.68	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	238.09	2.52	2.52	0.63	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	304.68	1.55	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	160.98	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	363.72	4.52	4.52	0.00	0.00	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	383.16	0.00	6.44	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	322.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	392.77	0.81	4.89	0.81	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	410.99	2.10	1.68	0.84	1.26	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	273.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	314.24	0.80	4.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	264.98	1.85	5.54	0.92	1.85	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	241.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	246.40	1.89	1.42	0.47	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	213.14	1.81	2.72	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	317.46	1.08	2.15	0.00	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	334.13	2.54	1.27	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	368.58	2.55	1.91	0.00	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	280.69	1.82	9.11	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	334.18	3.57	3.57	0.00	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	272.10	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	208.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	231.19	1.54	2.78	0.31	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	273.94	3.51	5.27	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	267.17	0.00	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	239.21	2.78	1.39	0.70	2.78	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	385.08	2.21	6.64	2.21	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	262.60	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	339.18	1.74	3.49	0.87	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	285.72	0.00	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	289.22	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	292.30	5.33	3.20	0.00	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	349.13	1.39	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	242.22	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	292.70	3.68	4.60	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	260.18	3.03	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	298.02	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	263.29	4.23	2.11	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	375.93	5.39	4.16	2.28	2.12	0.90
Keratinocyte - epidermal, donor2	11349-117G8	344.35	1.76	2.93	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	224.15	1.99	1.99	0.95	1.14	0.38
Keratinocyte - oral, donor1	11251-116E9	310.70	1.93	3.06	0.45	0.68	0.57
Keratocytes, donor1	11527-119I6	493.05	3.09	1.38	2.06	1.03	0.00
Keratocytes, donor2	11607-120I5	472.24	4.69	4.69	10.55	3.52	2.34
Keratocytes, donor3	11688-122I5	181.99	1.78	1.98	0.00	1.78	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	171.44	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	463.86	0.00	5.39	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	212.56	0.92	0.69	0.92	0.23	0.35
Lens Epithelial Cells, donor3	11690-122I7	497.18	1.31	1.21	1.01	0.71	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	284.47	3.08	3.79	0.24	1.42	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	220.19	3.35	2.51	1.95	1.40	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	194.88	2.52	3.62	0.79	1.89	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	239.28	1.08	1.61	1.08	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	277.35	1.89	4.10	1.26	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	235.79	2.48	5.07	0.75	1.94	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	200.68	2.05	1.23	1.23	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	285.94	1.77	5.06	0.76	0.76	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	259.12	2.39	4.79	0.42	1.55	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	245.63	1.98	2.37	0.40	1.58	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	242.16	1.94	2.52	1.16	1.16	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	269.21	3.89	3.70	1.11	1.67	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	224.73	1.39	4.18	0.35	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	312.94	3.10	3.34	1.19	1.19	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	278.40	3.16	3.43	0.55	1.79	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	258.68	2.46	3.08	0.92	2.46	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	269.66	1.56	3.12	1.56	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	333.41	3.66	3.84	1.28	1.28	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	239.92	3.29	3.29	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	311.03	2.64	2.05	1.46	2.05	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	307.68	5.48	6.72	1.24	1.49	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	260.91	3.39	3.88	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	281.41	1.89	3.23	1.62	1.35	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	285.50	3.78	5.75	1.36	2.42	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	237.95	3.63	4.67	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	281.00	1.88	2.51	1.26	1.05	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	293.68	4.21	4.66	0.90	2.26	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	286.16	3.44	4.82	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	270.37	2.45	3.20	1.13	1.88	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	301.76	3.18	5.73	1.27	1.70	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	283.48	3.39	2.42	0.97	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	295.73	2.98	3.64	2.65	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	294.74	4.46	4.58	1.36	3.10	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	249.52	3.70	4.81	0.37	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	246.09	2.47	2.22	1.48	1.73	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	294.65	3.16	6.05	1.37	2.20	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	253.45	3.22	2.89	0.64	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	307.68	2.43	3.04	0.61	1.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	270.27	3.78	3.92	0.56	1.68	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	236.45	2.13	2.84	0.36	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	317.53	5.33	3.39	0.48	3.39	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	293.01	5.45	4.05	0.31	2.18	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	250.32	2.15	2.51	0.36	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	352.48	3.59	2.94	1.31	1.63	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	254.02	3.06	3.30	1.88	1.65	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	348.48	4.21	4.70	0.74	2.72	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	343.72	3.84	3.33	1.54	2.31	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	243.76	3.28	2.39	1.19	2.98	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	70.25	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	84.38	1.53	2.30	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	77.93	0.00	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	101.55	3.81	2.12	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	95.65	0.70	1.41	0.00	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	87.79	0.93	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	85.53	2.06	2.58	0.00	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	95.16	0.00	3.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	95.68	1.58	0.45	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	79.11	1.45	2.62	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	84.63	2.70	4.50	0.90	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	157.16	0.95	2.03	0.14	1.08	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	119.14	1.54	2.57	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	100.56	1.76	1.76	1.41	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	81.96	0.00	3.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	113.59	1.53	5.60	0.00	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	102.19	0.80	1.87	0.00	1.33	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	111.67	1.89	3.02	0.76	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	121.49	1.23	2.45	0.00	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	161.45	6.52	4.89	0.82	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	118.07	1.87	2.71	0.21	0.83	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	105.10	1.68	3.36	0.00	0.84	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	138.07	1.03	3.09	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	137.89	2.90	4.64	0.00	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	107.61	1.49	1.49	0.30	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	127.80	0.00	1.11	1.11	3.32	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	194.42	2.47	4.95	0.00	2.47	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	130.92	2.58	5.16	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	125.49	1.15	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	169.23	3.84	4.99	1.92	2.30	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	158.52	3.96	5.66	1.70	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	159.17	0.00	3.28	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	189.34	2.71	2.71	0.00	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	171.64	2.15	4.31	0.72	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	214.36	0.75	4.48	1.49	3.73	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	213.67	5.20	7.43	0.37	1.86	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	121.47	1.72	2.15	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	165.27	2.57	3.43	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	172.92	5.66	3.33	1.33	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	138.16	1.81	2.41	2.41	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	143.62	1.42	0.00	2.13	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	146.42	3.78	2.06	1.03	1.72	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	109.50	2.68	1.61	1.07	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	138.71	2.02	4.04	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	143.35	1.85	3.70	1.11	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	111.64	0.00	0.00	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	124.81	1.06	4.23	2.12	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	161.26	2.40	2.80	1.20	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	103.22	2.18	0.00	0.00	0.00	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	118.81	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	88.79	1.97	2.96	0.49	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	106.33	1.88	3.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	139.78	2.01	1.01	0.50	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	146.45	5.41	2.25	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	175.55	3.44	5.16	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	171.90	1.78	1.78	0.89	1.78	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	170.88	2.35	5.47	0.78	1.56	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	166.25	1.32	1.32	2.64	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	179.55	3.11	1.56	2.08	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	172.40	4.81	5.25	0.00	1.75	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	191.21	5.59	3.35	1.68	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	227.89	3.53	3.53	1.77	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	200.19	3.86	3.47	0.39	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	237.48	6.58	4.05	2.53	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	261.94	3.84	4.33	1.92	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	215.87	3.18	6.76	1.99	2.39	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	265.53	4.25	4.25	1.22	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	215.81	2.08	4.84	3.46	5.53	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	269.79	3.42	3.42	2.66	3.42	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	256.66	5.16	11.36	3.10	2.07	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	323.49	4.23	10.88	3.63	2.42	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	250.67	2.22	7.61	1.27	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	291.60	1.60	7.46	5.33	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	298.83	3.45	9.19	4.02	4.02	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	362.54	8.23	12.34	4.63	4.11	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	379.14	4.95	8.49	6.37	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	394.40	8.51	12.48	5.11	1.70	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	375.67	6.66	12.90	3.74	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	459.65	3.92	8.61	3.13	3.92	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	469.32	7.52	11.27	11.27	5.01	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	465.57	5.58	10.22	4.65	1.39	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	457.63	6.02	7.36	4.68	1.34	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	542.13	9.09	11.76	8.02	4.28	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	575.43	10.51	22.23	6.06	4.85	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	392.80	5.51	7.34	2.75	1.84	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	466.78	11.56	15.11	11.56	6.22	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	551.06	9.12	11.97	5.70	3.99	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	354.31	3.07	3.07	3.83	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	332.68	8.21	10.94	3.83	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	416.05	5.35	6.24	4.90	2.23	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	306.75	2.08	2.34	2.60	1.82	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	281.82	5.30	3.32	4.64	1.99	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	351.29	4.16	12.47	0.00	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	335.95	1.14	1.60	2.51	0.91	1.82
Macrophage - monocyte derived, donor2	11313-117C8	449.96	5.87	1.65	16.15	2.57	0.73
Macrophage - monocyte derived, donor3	11389-118C3	543.20	6.42	5.51	18.88	3.41	1.84
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	187.45	1.59	0.53	1.06	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	427.66	5.07	2.54	0.79	1.43	1.27
Mallassez-derived cells, donor3	11930-125I4	399.59	4.59	3.20	1.53	1.53	1.11
Mammary Epithelial Cell, donor1	11273-116H4	279.90	1.30	1.99	1.59	0.80	0.10
Mammary Epithelial Cell, donor2	11350-117G9	245.83	1.74	0.87	0.58	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	372.64	1.50	3.99	2.24	1.75	0.75
Mast cell - stimulated, donor1	11487-119E2	244.06	10.85	6.10	0.00	4.75	2.03
Mast cell, donor1	11563-120D6	264.84	4.00	4.22	0.11	3.46	1.19
Mast cell, donor2	11565-120D8	117.09	6.54	3.27	0.30	2.38	0.89
Mast cell, donor3	11566-120D9	123.59	6.53	4.50	0.68	2.03	2.25
Mast cell, donor4	11567-120E1	100.88	5.32	3.19	0.35	3.90	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	126.42	1.77	2.11	0.33	1.33	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	134.25	5.25	4.67	1.17	1.17	1.75
Mast cell, expanded, donor5	11939-126A4	103.48	2.75	2.18	0.57	1.15	0.69
Mast cell, expanded, donor8	11941-126A6	225.28	10.21	11.05	0.17	3.85	3.01
Melanocyte - dark, donor1	11502-119F8	186.66	0.60	0.70	0.00	0.30	0.30
Melanocyte - dark, donor2	11582-120F7	305.94	1.04	4.15	0.35	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	95.91	0.14	0.14	0.07	0.22	0.14
Melanocyte - light, donor1	11274-116H5	142.92	6.58	2.12	0.00	2.35	1.41
Melanocyte - light, donor2	11351-117H1	133.76	4.09	1.36	0.00	0.00	1.36
Melanocyte - light, donor3	11423-118G1	191.66	5.20	0.87	0.87	4.34	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	95.59	0.83	0.94	0.21	1.25	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	76.65	0.00	0.27	0.00	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	77.95	1.07	0.80	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	1078.33	2.98	4.84	9.30	1.36	1.24
Meningeal Cells, donor2	11573-120E7	636.89	5.72	7.04	5.28	2.64	0.88
Meningeal Cells, donor3	11654-122E7	636.77	2.93	3.99	8.15	0.98	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	355.02	1.71	1.71	5.13	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	233.57	2.21	0.91	0.81	0.40	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1726.81	21.03	13.14	6.57	2.63	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	697.25	2.62	6.54	7.85	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	327.95	1.44	3.59	2.15	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	624.93	9.95	7.84	2.12	5.29	3.39
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	516.22	13.07	11.56	1.01	4.52	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	550.04	1.54	2.64	5.27	0.22	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	749.58	5.84	8.77	38.72	2.92	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	584.35	4.30	4.91	12.69	1.43	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	257.62	1.25	1.25	0.83	0.42	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	672.08	5.58	3.35	0.37	2.23	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	334.20	0.92	1.97	0.66	0.53	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	381.61	3.86	2.08	0.89	1.19	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	422.73	9.34	9.34	4.67	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	405.37	3.20	3.20	0.64	2.56	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	343.10	0.35	1.06	0.35	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	285.83	2.19	0.31	0.94	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	211.18	0.73	2.90	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	243.70	4.24	1.06	0.53	2.39	1.59
Mesothelial Cells, donor2	12156-128G5	399.37	5.00	2.50	1.00	3.50	0.50
Mesothelial Cells, donor3	11402-118D7	368.91	6.21	4.99	1.95	3.61	1.30
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1281.46	5.40	0.00	60.76	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	637.60	5.42	6.65	42.36	3.94	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	740.27	7.95	5.59	58.89	3.24	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	715.62	6.91	0.00	48.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	340.63	5.89	4.34	17.67	1.24	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	547.21	3.94	6.02	42.73	3.94	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	581.33	11.58	0.00	37.06	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	569.10	6.01	8.76	33.54	4.00	3.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	750.35	4.19	2.33	62.37	2.33	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	661.85	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	565.75	6.10	5.69	39.02	3.86	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	570.98	5.94	1.98	52.66	1.58	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	487.43	0.00	0.00	17.10	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	426.54	8.85	9.73	22.12	6.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	556.61	4.56	6.08	40.65	0.38	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	496.10	2.63	0.00	30.27	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	422.11	7.64	7.43	26.95	1.91	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	463.17	1.84	0.00	33.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	457.81	2.98	3.58	21.46	2.09	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	598.57	3.35	0.00	51.98	1.68	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	678.99	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	338.72	5.52	6.02	13.05	1.76	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	493.40	3.09	1.90	43.97	1.66	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	363.80	4.98	1.11	23.22	1.11	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	311.06	4.14	3.91	14.74	2.99	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	428.04	3.58	3.16	33.23	2.52	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	375.25	2.85	5.30	17.73	2.45	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	314.51	2.57	5.36	15.45	1.07	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	474.37	2.45	0.89	33.12	0.89	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	381.78	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	254.28	2.41	2.63	10.07	1.75	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	485.66	3.04	0.00	33.97	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	250.21	4.97	0.00	18.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	334.58	5.44	2.17	17.94	0.27	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	361.13	2.94	0.59	22.35	1.18	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	275.85	4.36	3.27	10.90	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	219.13	1.92	1.44	11.05	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	304.17	6.00	3.60	20.81	1.60	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	282.47	1.37	0.00	5.48	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	243.78	2.50	0.00	10.51	1.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	350.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	285.39	8.15	0.00	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	206.70	0.00	0.88	5.69	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	358.69	3.31	0.00	26.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	359.26	3.84	0.64	8.33	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	258.83	2.48	3.97	6.69	0.74	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	365.35	0.00	0.70	22.96	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	373.47	0.00	0.00	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	307.00	1.71	3.76	5.81	2.39	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	361.03	3.06	0.88	21.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	344.09	3.55	0.36	4.62	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	304.96	2.24	4.49	6.73	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	294.26	3.33	0.83	14.13	0.83	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	349.65	2.91	0.00	5.24	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	348.12	3.62	5.73	5.13	2.11	2.41
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	279.65	1.67	1.25	15.03	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	411.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	244.74	6.46	4.62	3.69	2.77	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	387.00	3.98	5.69	24.47	2.28	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	341.86	3.45	1.11	3.73	2.07	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	257.59	2.59	3.11	5.70	1.30	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	426.40	4.72	2.14	18.45	0.86	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	346.81	1.27	0.00	4.45	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	260.48	3.74	2.40	3.74	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	365.18	2.99	3.59	13.77	2.10	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	277.28	2.97	0.71	3.96	1.13	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	236.97	2.23	2.87	3.82	1.27	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	384.55	2.21	2.87	21.01	3.32	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	337.87	3.03	0.38	3.03	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	237.23	3.41	1.70	4.26	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	368.71	3.93	4.42	16.96	0.49	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	313.45	5.21	0.65	1.96	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	279.91	2.65	3.53	4.70	1.76	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	354.06	3.75	1.73	13.84	3.75	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	462.84	6.59	1.24	5.36	2.06	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	271.88	4.17	1.49	4.17	1.19	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	143.14	0.00	3.77	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	137.23	3.56	1.78	1.78	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	369.64	1.31	6.24	1.31	2.30	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	334.52	1.05	2.10	4.21	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	211.52	1.38	1.58	2.97	1.58	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	468.45	7.45	3.73	5.59	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	490.82	2.63	6.01	7.14	3.76	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	440.53	5.06	4.26	16.78	0.80	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	284.56	1.24	1.47	0.68	0.79	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	348.47	2.95	3.68	2.21	2.95	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	283.98	2.56	8.43	0.37	1.83	2.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	437.12	10.89	23.33	6.22	4.67	7.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	365.56	2.14	2.67	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	355.48	7.73	7.73	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	432.25	3.03	9.09	3.03	2.02	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	363.45	2.11	5.48	2.95	2.11	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	95.34	1.36	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	39.42	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	23.49	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	108.75	0.00	1.51	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	5.71	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	166.38	3.26	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	237.62	0.00	4.75	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	163.14	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	512.95	4.09	4.31	0.43	1.72	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	356.42	3.66	9.41	0.00	2.61	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	357.77	6.01	2.00	1.33	2.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	453.68	5.01	1.67	4.17	0.83	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	227.03	5.13	4.37	1.90	2.85	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	595.25	1.60	0.00	7.98	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	225.74	1.36	2.04	1.36	0.68	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	391.42	16.54	1.84	5.51	16.54	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	191.27	4.19	2.09	0.42	0.42	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	230.11	2.09	1.86	1.16	0.70	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	287.79	6.22	2.70	1.35	2.43	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	292.23	3.78	2.94	0.21	2.52	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	11.13	11.13	0.00	44.54	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	239.74	6.95	2.98	0.50	2.48	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	138.31	2.98	1.89	0.54	1.35	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	234.16	4.99	4.08	1.36	1.81	2.95
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	284.31	5.06	3.27	2.45	1.80	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	291.79	4.74	3.83	1.46	1.46	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	266.81	5.30	2.12	4.24	0.53	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	382.99	12.01	6.00	0.00	1.20	4.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	166.71	7.55	5.58	0.66	3.61	3.28
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	274.67	5.04	2.93	1.79	1.79	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	394.57	4.94	2.12	1.59	1.59	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	232.77	5.63	5.63	1.41	0.00	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	265.71	2.30	1.84	1.84	3.68	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	221.41	3.21	2.57	0.32	2.25	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	264.18	10.00	8.28	1.03	7.24	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	874.84	10.11	0.00	2.53	20.23	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	329.05	3.12	0.89	0.89	0.89	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	204.50	3.39	3.39	2.54	2.54	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	175.88	4.51	3.09	2.14	0.71	2.14
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	223.21	3.00	2.58	1.29	1.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	252.78	18.06	9.03	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	267.58	3.33	3.33	0.00	2.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	351.67	4.51	0.45	2.25	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	163.48	2.38	1.19	1.19	1.19	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	253.52	11.14	6.50	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	124.86	3.41	2.27	0.76	1.51	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	282.87	4.56	2.61	0.98	2.61	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	299.38	2.18	1.31	0.87	1.74	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	364.09	4.52	0.00	0.90	3.17	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	215.19	4.41	3.53	1.76	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	254.64	5.32	2.66	2.66	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	210.82	3.97	4.46	0.00	1.98	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	261.85	3.83	1.91	1.53	0.38	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	150.62	1.51	1.81	1.81	1.51	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	297.50	4.20	1.55	1.11	2.43	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	186.36	2.03	4.07	0.68	2.03	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	347.45	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	168.27	1.83	0.61	0.61	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	184.75	2.52	1.26	0.31	1.26	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	221.54	4.24	1.51	1.82	0.91	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	177.22	3.96	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	229.00	9.07	4.53	1.13	11.34	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	227.60	0.00	10.12	5.06	15.17	0.00
Myoblast, donor1	11241-116D8	278.15	2.98	1.99	1.24	0.50	0.87
Myoblast, donor2	11322-117D8	369.00	6.90	8.44	4.03	1.92	2.30
Myoblast, donor3	11398-118D3	313.96	2.86	1.68	0.84	1.18	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	133.24	1.31	1.31	0.29	0.29	0.58
Natural Killer Cells, donor1	11230-116C6	214.95	2.15	1.23	0.62	0.92	1.54
Natural Killer Cells, donor2	11311-117C6	201.74	3.92	4.22	1.51	2.11	1.51
Natural Killer Cells, donor3	11387-118C1	207.80	3.68	3.31	0.55	1.10	0.74
Neural stem cells, donor1	11275-116H6	516.10	8.35	7.98	3.27	3.99	2.18
Neural stem cells, donor2	11352-117H2	462.15	1.93	7.70	1.93	0.00	0.00
Neurons, donor1	11494-119E9	308.37	2.28	4.55	3.41	2.28	1.14
Neurons, donor2	11574-120E8	179.87	1.10	1.10	1.32	0.88	0.66
Neurons, donor3	11655-122E8	199.79	4.93	4.93	0.82	3.29	0.82
Neutrophils, donor1	11233-116C9	2068.52	24.13	43.62	6.50	15.78	29.70
Neutrophils, donor2	11314-117C9	1536.40	63.78	43.48	5.80	26.09	49.28
Neutrophils, donor3	11390-118C4	2573.48	36.04	50.70	4.28	23.82	45.20
Nucleus Pulposus Cell, donor1	11252-116F1	769.64	3.32	6.17	5.70	3.32	1.90
Nucleus Pulposus Cell, donor2	11409-118E5	664.56	4.88	6.84	3.91	3.26	2.60
Nucleus Pulposus Cell, donor3	11462-119B4	377.64	2.81	3.81	2.41	2.01	0.60
Olfactory epithelial cells, donor1	11933-125I7	421.90	4.96	5.23	1.38	1.51	1.65
Olfactory epithelial cells, donor2	11934-125I8	426.13	7.82	11.58	1.16	3.91	3.18
Olfactory epithelial cells, donor3	11935-125I9	391.48	2.95	5.56	0.68	1.93	0.79
Olfactory epithelial cells, donor4	11936-126A1	392.90	3.31	3.31	1.56	1.75	1.56
Oligodendrocyte - precursors, donor1	11496-119F2	309.94	0.00	1.81	1.20	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	347.12	5.32	1.91	2.13	3.83	1.28
Osteoblast - differentiated, donor2	11353-117H3	140.60	13.72	8.00	0.00	6.86	3.43
Osteoblast - differentiated, donor3	11425-118G3	225.94	5.59	4.97	0.00	2.48	0.62
Osteoblast, donor1	11277-116H8	821.03	5.28	5.28	2.35	1.76	1.37
Osteoblast, donor2	11354-117H4	638.41	3.51	4.21	2.11	0.70	0.00
Osteoblast, donor3	11426-118G4	574.96	4.62	3.20	1.42	2.49	1.96
Pancreatic stromal cells, donor1	11249-116E7	445.69	13.65	6.74	2.11	5.31	2.61
Pericytes, donor1	11491-119E6	495.80	5.34	3.45	1.34	2.78	1.56
Pericytes, donor2	11571-120E5	430.77	4.98	5.89	1.58	2.94	1.13
Pericytes, donor3	11652-122E5	592.85	4.48	6.51	2.03	3.66	1.42
Perineurial Cells, donor1	11499-119F5	354.66	1.36	1.13	1.58	0.34	0.23
Perineurial Cells, donor2	11579-120F4	358.20	1.66	2.12	0.83	1.20	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	580.42	3.82	1.91	2.55	2.87	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	423.86	9.30	9.55	3.67	3.92	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	431.99	4.53	5.44	2.46	3.36	1.42
Placental Epithelial Cells, donor1	11278-116H9	240.12	3.11	1.67	0.24	2.15	0.96
Placental Epithelial Cells, donor2	11355-117H5	351.52	2.22	6.65	0.00	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	279.37	2.55	4.12	1.18	1.77	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	347.78	10.76	12.34	0.32	5.38	0.95
Preadipocyte - breast, donor1	11467-119B9	312.33	7.69	4.50	1.50	1.50	2.06
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	283.51	1.04	1.70	1.57	0.65	0.52
Preadipocyte - breast, donor2	11328-117E5	385.23	10.13	13.06	0.90	4.05	1.35
Preadipocyte - omental, donor1	11468-119C1	299.32	7.46	5.43	2.77	2.66	1.49
Preadipocyte - omental, donor2	11329-117E6	344.38	8.29	6.55	1.31	2.62	0.44
Preadipocyte - omental, donor3	11403-118D8	516.98	7.59	5.87	3.72	5.16	2.44
Preadipocyte - perirenal, donor1	11469-119C2	353.35	2.95	3.94	1.97	2.95	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	822.77	10.13	5.22	3.07	1.54	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	650.94	6.55	17.35	5.67	3.90	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	611.66	7.83	9.37	3.58	6.47	3.24
Preadipocyte - visceral, donor1	11280-116I2	585.34	6.33	4.19	4.01	2.42	1.30
Preadipocyte - visceral, donor2	11357-117H7	343.29	7.82	11.04	0.92	4.60	3.22
Preadipocyte - visceral, donor3	11429-118G7	472.92	6.48	9.51	7.11	4.81	2.30
Prostate Epithelial Cells (polarized), donor1	11253-116F2	236.84	13.73	8.00	0.91	5.88	3.77
Prostate Epithelial Cells, donor2	11331-117E8	266.90	14.35	18.01	2.17	3.11	1.62
Prostate Epithelial Cells, donor3	11404-118D9	132.52	6.80	3.98	0.86	3.18	1.10
Prostate Stromal Cells, donor1	11254-116F3	361.29	7.97	5.81	1.14	2.39	0.57
Prostate Stromal Cells, donor2	11332-117E9	411.67	6.99	9.86	2.33	2.69	1.08
Prostate Stromal Cells, donor3	11405-118E1	368.51	13.35	13.97	0.63	7.20	2.50
Renal Cortical Epithelial Cells, donor1	11516-119H4	370.46	2.55	0.73	0.73	1.82	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	193.24	1.18	0.97	0.28	0.35	0.28
Renal Epithelial Cells, donor1	11517-119H5	670.56	2.03	1.52	1.52	1.01	2.54
Renal Epithelial Cells, donor2	11597-120H4	308.00	0.71	4.98	1.42	0.00	2.13
Renal Epithelial Cells, donor3	11678-122H4	247.30	1.69	2.43	0.21	0.95	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	488.85	4.77	8.17	4.77	4.77	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	420.60	5.53	6.74	4.18	2.02	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	287.95	3.77	2.44	1.11	1.11	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	686.07	3.33	8.65	2.00	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	619.77	3.74	3.08	3.52	2.20	1.32
Renal Mesangial Cells, donor2	11598-120H5	469.61	5.02	3.13	0.63	1.25	1.25
Renal Mesangial Cells, donor3	11679-122H5	592.27	4.72	4.16	0.55	6.10	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	223.33	1.61	1.07	0.00	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	158.13	2.53	2.11	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	415.59	3.09	3.47	3.09	1.35	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	152.46	0.26	1.04	1.30	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	429.78	3.98	3.13	1.14	0.28	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	382.83	2.06	2.06	3.09	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	345.50	2.26	4.01	1.25	2.01	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	225.18	4.14	2.81	2.54	1.34	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	28.07	1.65	1.10	0.00	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.78	0.58	1.16	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	120.53	1.04	1.17	0.78	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	113.21	0.99	1.49	0.20	0.30	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	93.02	0.67	0.45	0.00	0.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	116.35	0.50	1.74	0.50	0.87	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	143.00	1.52	1.52	0.82	1.28	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	132.67	0.92	1.39	0.69	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	128.97	0.96	0.96	0.55	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	130.55	1.82	1.82	0.45	0.76	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	90.13	0.36	0.00	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	125.81	1.43	1.58	0.86	0.43	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	133.18	0.97	2.25	0.21	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	125.46	0.89	2.21	0.66	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	133.63	0.96	0.19	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	146.08	1.30	1.12	0.37	0.65	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	118.01	0.75	1.32	0.56	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	169.33	0.80	0.27	0.53	0.93	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	144.65	0.88	2.04	0.49	0.68	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	128.32	0.57	2.10	0.95	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	153.46	1.28	0.96	0.64	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	133.43	1.96	2.24	0.00	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	121.00	1.20	1.03	0.68	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	143.86	0.00	0.73	0.36	0.73	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	148.14	2.21	1.84	0.25	0.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	117.26	1.21	1.07	0.27	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	148.84	1.18	2.12	0.24	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	138.29	1.59	1.59	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	128.15	0.94	1.64	1.17	0.23	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	149.92	1.04	1.45	0.83	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	141.57	1.99	2.65	0.22	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	129.93	0.84	0.00	0.63	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	168.37	1.08	1.75	0.54	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	166.72	1.70	1.36	0.68	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	135.34	0.58	1.93	0.19	0.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	164.03	1.03	2.75	0.69	0.52	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	168.03	0.82	0.82	0.69	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	148.74	1.15	2.63	0.66	0.66	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	108.39	0.85	1.19	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	124.58	0.59	0.44	0.00	1.04	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	116.48	0.00	0.27	0.00	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	76.05	0.69	0.55	0.28	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	77.38	0.71	0.71	0.00	1.19	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	107.42	0.81	1.01	0.20	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.66	0.66	0.66	0.38	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.72	2.10	1.05	1.05	0.70	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	49.26	0.60	1.21	0.00	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	60.95	0.49	1.47	0.24	0.37	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.75	0.15	0.87	0.58	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.89	0.61	1.22	0.00	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	65.70	0.30	1.21	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	67.40	2.26	4.52	0.90	2.04	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	61.71	0.60	0.90	0.90	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	59.63	1.89	1.77	0.12	1.53	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	48.45	2.35	2.77	0.43	0.64	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	46.28	1.20	0.00	0.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	521.90	2.26	5.08	4.14	3.20	1.13
Schwann Cells, donor2	11578-120F3	268.79	6.80	3.40	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	330.59	1.75	4.16	1.31	0.22	0.44
Sebocyte, donor1	11220-116B5	1195.23	10.96	13.15	7.12	2.74	3.29
Sebocyte, donor2	11301-117B5	547.33	12.87	17.46	1.84	7.81	0.92
Sebocyte, donor3	11378-118B1	484.36	9.28	8.24	2.06	4.33	1.03
Sertoli Cells, donor1	11255-116F4	392.61	0.00	4.97	0.00	6.63	1.66
Sertoli Cells, donor2	11333-117F1	316.33	14.12	22.59	5.65	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	462.85	8.45	6.42	1.67	4.93	2.11
Skeletal Muscle Cells, donor2	11358-117H8	275.40	8.67	2.89	1.45	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	847.74	10.03	15.05	6.69	2.51	5.02
Skeletal Muscle Cells, donor4	11451-119A2	463.27	4.56	7.23	5.97	1.73	0.47
Skeletal Muscle Cells, donor5	11455-119A6	397.62	4.91	7.43	3.42	2.53	1.34
Skeletal Muscle Cells, donor6	11459-119B1	349.67	3.85	7.08	3.39	1.85	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	510.45	6.43	5.54	1.26	3.15	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	505.55	6.71	9.99	2.71	3.00	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	460.83	5.56	5.95	5.95	1.98	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	429.18	4.21	2.95	0.93	1.01	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	581.91	5.79	10.13	4.34	2.90	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	395.46	5.78	9.63	2.34	3.44	0.83
Skin - palm, donor1	10286-104F7	123.56	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	182.65	9.37	3.03	2.45	2.59	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	227.37	3.27	8.18	0.82	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	184.36	7.40	3.64	2.08	1.43	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	216.85	9.45	4.31	1.95	2.50	1.81
Small Airway Epithelial Cells, donor2	11334-117F2	352.21	15.89	6.05	2.67	3.09	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	237.03	1.90	0.85	2.96	0.85	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	271.62	9.22	2.92	1.72	3.90	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	473.06	11.11	11.42	2.78	5.55	4.32
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	277.47	5.78	5.56	4.00	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	631.33	2.94	2.94	5.29	2.94	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	488.17	3.98	4.86	1.99	0.44	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	616.27	4.33	2.76	1.58	3.94	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	604.15	2.32	1.55	3.09	3.09	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	235.18	2.00	2.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	694.67	10.11	7.32	1.06	3.73	2.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	440.43	4.65	7.31	1.99	3.55	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	61.07	2.30	1.15	0.77	0.51	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	238.98	0.98	0.65	1.95	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	410.50	2.07	2.36	0.00	1.48	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	377.55	3.42	4.41	1.00	1.42	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1025.83	5.53	4.39	7.48	2.11	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	472.78	5.78	3.04	2.74	0.91	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	705.91	9.09	6.57	3.79	4.29	2.53
Smooth Muscle Cells - Carotid, donor2	11362-117I3	391.73	0.00	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	576.02	9.06	14.31	0.48	6.20	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	310.73	1.33	2.06	0.44	1.62	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	259.58	5.38	6.03	1.08	2.37	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	289.58	3.99	4.62	1.47	1.89	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	700.08	8.82	4.02	1.86	2.78	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	519.54	4.31	6.47	4.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	327.85	2.69	3.59	1.49	1.49	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	986.99	2.05	1.71	7.51	3.41	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	411.96	1.41	2.04	1.57	0.71	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	558.26	38.34	19.93	9.26	11.67	5.54
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	294.91	2.50	4.32	0.91	2.50	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	469.77	3.02	15.70	1.81	3.62	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	383.08	1.32	3.71	3.71	1.32	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	325.44	4.66	3.60	0.53	3.46	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	315.05	10.52	8.77	0.75	3.01	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	280.04	2.79	1.52	0.25	2.03	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	514.14	6.03	4.07	2.86	3.17	1.81
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	414.84	5.25	12.00	11.25	3.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	511.72	20.68	10.34	0.00	5.17	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	548.78	6.98	4.65	3.26	1.86	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	457.93	7.57	9.59	2.52	4.54	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	484.51	10.97	14.73	4.70	5.33	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	429.81	2.95	2.95	0.88	2.06	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	488.51	0.25	0.33	4.17	0.42	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	421.38	0.47	3.27	4.20	2.80	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	660.01	6.33	4.61	1.01	1.44	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	768.18	11.47	12.24	2.55	5.61	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	564.85	4.70	9.78	2.63	2.44	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	395.34	1.12	1.40	1.82	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	506.58	1.01	1.26	1.01	0.84	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	325.71	2.38	4.29	0.48	1.43	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	721.02	6.12	3.91	0.98	3.67	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	677.65	17.45	11.49	5.30	8.18	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	352.85	3.22	1.76	3.51	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	181.14	5.64	3.50	0.78	2.92	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	339.82	9.26	7.67	2.64	3.17	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	152.87	9.30	11.53	0.74	5.21	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	396.71	8.62	6.11	2.52	3.95	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	268.00	2.56	2.27	1.14	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	355.66	9.06	8.67	0.79	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	206.46	11.68	6.35	0.51	2.03	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	253.17	12.78	5.19	0.80	3.99	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	229.90	6.27	5.85	0.00	2.93	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	156.30	4.13	0.92	0.46	1.38	0.46
Synoviocyte, donor1	11291-117A4	1019.69	8.08	9.43	7.24	5.89	4.88
Synoviocyte, donor2	11368-117I9	294.68	6.03	4.19	0.34	5.70	1.17
Synoviocyte, donor3	11440-118H9	333.33	6.03	8.04	1.34	4.02	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	1018.04	3.22	3.22	19.30	1.43	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	469.74	1.98	1.98	0.00	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	985.93	6.95	11.11	16.90	1.62	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	226.24	2.01	1.94	1.00	0.36	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	402.41	3.09	6.19	2.32	1.93	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	433.51	8.02	9.16	2.86	3.44	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	211.48	3.81	3.32	1.48	1.72	1.85
Urethra, donor2	10319-105A4	232.00	3.60	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	451.36	1.06	2.66	2.13	1.33	1.59
Urothelial Cells, donor2	11600-120H7	298.82	3.20	3.61	0.80	1.20	0.40
Urothelial Cells, donor3	11681-122H7	308.51	1.83	4.58	0.23	1.15	1.15
Urothelial cells, donor0	11216-116B1	368.00	1.56	0.89	0.45	0.89	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	977.87	2.67	5.34	3.56	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	932.11	2.86	5.72	4.29	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	847.44	8.90	10.95	5.48	2.05	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	574.36	1.38	3.44	1.03	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	657.72	2.91	2.91	1.16	1.16	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	1079.77	1.04	6.25	5.21	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	905.86	0.92	5.51	3.67	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	671.89	1.83	17.35	0.91	2.74	1.83
Wilms' tumor cell line:G-401	10809-111A8	156.79	1.36	1.73	0.49	0.37	1.11
Wilms' tumor cell line:HFWT	10597-108E3	122.33	0.00	0.00	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	39.10	0.00	0.84	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	152.92	2.07	2.07	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	9.43	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.14	0.23	0.00	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	108.14	0.59	0.47	0.24	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	80.27	0.27	0.27	1.09	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	240.89	1.97	4.78	2.53	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	156.50	1.27	0.42	1.27	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	436.90	2.72	7.89	1.91	1.63	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	298.31	3.53	4.85	1.32	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	303.82	2.86	3.27	2.04	1.23	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	228.32	1.94	3.49	2.33	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	210.13	1.84	2.76	0.74	0.37	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	128.72	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	427.35	4.65	6.51	3.95	1.63	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	684.54	4.92	7.25	6.73	2.85	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	518.73	4.09	4.09	1.17	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	169.64	0.93	0.00	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	416.19	2.88	4.11	0.41	1.65	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	452.14	3.38	0.31	0.61	0.92	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	369.96	0.85	2.13	1.28	0.85	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	430.68	2.43	2.43	1.52	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	398.61	1.68	1.20	0.96	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	311.83	1.78	2.23	1.11	0.45	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	47.03	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	155.56	0.38	1.51	0.38	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	223.30	1.74	0.44	1.74	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	217.44	1.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	198.76	2.83	0.00	0.47	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	349.02	5.58	5.58	3.10	1.86	5.12
adipose, donor1	10184-103D4	86.79	4.10	2.93	0.59	2.93	2.35
adipose, donor2	10185-103D5	129.77	8.11	2.43	0.81	0.81	0.81
adipose, donor3	10186-103D6	115.72	4.36	2.18	0.54	1.91	1.09
adipose, donor4	10187-103D7	158.62	3.47	4.33	1.73	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	276.19	1.74	0.95	3.63	0.32	0.95
adrenal gland, adult, pool1	10081-102A9	47.29	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	69.90	0.67	0.13	0.27	0.27	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	131.84	1.79	0.71	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	84.39	0.70	0.23	0.23	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	91.96	1.35	1.69	0.00	1.35	1.01
amniotic membrane cells, donor3	12237-129G5	57.74	0.00	0.88	0.00	0.59	0.00
amygdala - adult, donor10196	10167-103B5	53.36	0.00	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	60.42	1.01	0.81	1.01	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	69.72	0.00	0.65	0.32	1.29	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	160.05	1.78	0.64	0.51	0.64	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	144.07	1.54	1.54	0.00	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	63.47	0.00	1.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	475.62	3.53	6.67	0.98	2.35	1.37
appendix, adult	10189-103D9	345.04	5.05	3.49	0.39	3.88	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	3.78	0.34	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	210.60	10.87	1.36	0.00	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	203.83	1.01	1.30	1.01	0.58	0.29
b cell line:RPMI1788	10427-106D4	61.56	0.30	0.15	0.74	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	544.07	7.21	4.44	2.22	5.55	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	124.34	0.89	0.69	1.09	0.50	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	31.97	0.33	0.17	0.17	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	305.34	2.80	1.12	2.24	1.12	0.00
bladder, adult, pool1	10011-101C2	637.72	10.76	9.34	0.98	5.87	2.82
blood, adult, pool1	10053-101G8	551.44	11.07	8.86	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	632.84	4.28	0.00	0.86	0.86	0.86
bone marrow, adult	10192-103E3	184.90	0.67	6.75	1.35	0.00	1.35
brain, adult, donor1	10084-102B3	65.60	1.03	2.05	0.00	2.05	2.05
brain, adult, pool1	10012-101C3	122.27	1.22	1.22	0.56	0.45	0.33
brain, fetal, pool1	10085-102B4	138.91	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	147.34	0.99	1.65	0.33	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	129.32	0.50	0.12	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	179.94	2.53	1.26	1.26	1.89	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	72.67	0.38	0.89	0.25	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.09	0.00	0.62	0.31	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	85.18	2.07	1.84	0.23	0.23	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.43	1.45	0.48	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	4.23	0.00	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	127.10	0.55	0.33	0.55	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	81.44	0.00	0.00	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	97.15	1.06	2.13	0.53	0.80	1.06
caudate nucleus - adult, donor10196	10177-103C6	50.66	1.15	3.45	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	56.56	1.17	1.51	0.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	21.40	0.00	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	70.68	0.37	0.37	1.10	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	107.79	2.91	2.91	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	139.64	2.14	2.99	0.21	0.85	0.21
cerebellum, adult, pool1	10083-102B2	84.17	0.69	1.38	0.00	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	161.08	0.83	3.32	2.49	1.66	0.83
cerebral meninges, adult	10188-103D8	89.01	1.51	1.51	0.76	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	72.36	1.46	0.00	0.73	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	77.93	0.58	0.58	0.14	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	109.70	0.33	0.33	0.00	0.00	0.17
cervix, adult, pool1	10013-101C4	547.73	10.50	5.25	1.57	5.14	2.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	244.82	1.67	2.37	0.56	0.98	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	363.14	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	92.96	2.73	1.62	0.00	1.24	0.50
choriocarcinoma cell line:SCH	10785-110H2	67.27	0.12	0.62	0.12	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	38.42	1.66	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	131.35	1.71	1.42	1.42	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	520.52	13.62	7.26	2.88	9.84	4.18
chorionic membrane cells, donor3	12240-129G8	136.27	1.65	2.75	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	383.24	3.07	0.96	1.92	0.96	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	88.49	0.84	0.42	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	141.50	1.54	1.80	0.51	0.51	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	162.78	0.97	2.18	0.73	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	266.12	2.24	3.46	0.81	0.61	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	95.99	0.88	0.59	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	190.00	0.52	0.52	0.26	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	64.23	1.14	1.37	0.23	0.69	0.91
clear cell carcinoma cell line:TEN	10636-108I6	143.32	1.91	2.78	0.69	0.35	0.87
colon carcinoma cell line:CACO-2	10513-107D9	176.27	0.92	0.37	0.55	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	253.13	0.76	2.28	0.76	0.38	0.00
colon, adult, donor1	10082-102B1	196.36	2.38	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	252.04	7.17	3.17	0.71	4.11	1.29
colon, fetal, donor1	10070-101I7	208.88	4.33	8.03	1.85	3.71	3.09
common myeloid progenitor CMP, donor1	12130-128D6	362.10	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	45.47	0.00	0.85	0.42	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	53.43	0.30	0.75	0.30	0.45	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	52.60	0.14	0.00	0.42	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	121.29	0.44	0.33	0.22	0.44	0.00
cruciate ligament, donor2	10295-104G7	146.70	2.43	2.43	1.62	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	146.07	0.80	3.21	0.00	0.00	0.80
diencephalon, adult	10193-103E4	41.28	0.72	0.72	0.00	0.00	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.56	0.00	0.23	0.00	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	98.47	0.26	0.51	0.51	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	187.76	2.65	0.48	0.72	0.24	0.00
ductus deferens, adult	10196-103E7	165.45	1.99	1.99	0.00	2.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	133.94	0.00	5.76	2.88	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	198.63	4.41	10.30	0.74	2.21	1.47
dura mater, adult, donor1	10041-101F5	693.57	4.05	6.61	2.06	2.73	2.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	79.72	4.66	1.78	0.67	1.55	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	71.07	1.00	1.15	0.72	0.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	201.63	0.62	0.00	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	204.33	2.42	1.82	0.30	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	198.53	2.16	0.31	0.93	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	249.56	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	105.92	0.34	0.34	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	263.34	2.36	1.09	1.27	0.54	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	86.52	2.09	1.93	0.00	0.64	0.32
epidermoid carcinoma cell line:A431	10426-106D3	177.52	1.78	0.11	0.44	0.67	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	251.76	1.10	0.66	0.66	0.44	0.44
epididymis, adult	10197-103E8	285.71	6.07	3.56	0.63	1.47	6.91
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	215.38	1.77	0.71	1.24	0.53	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	283.53	3.54	1.97	1.97	1.97	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	165.12	1.31	3.15	0.92	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	139.56	0.69	3.84	0.59	0.30	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	166.14	1.90	2.46	0.67	1.12	0.22
esophagus, adult, pool1	10015-101C6	346.46	7.54	6.37	0.85	3.08	2.23
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1288.43	23.79	7.01	47.09	5.51	3.38
eye - muscle inferior rectus, donor1	10272-104E2	106.24	7.24	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	90.48	2.10	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	59.53	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	115.80	4.59	0.00	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	128.25	0.00	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	125.34	0.51	4.07	0.25	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	281.45	2.44	1.67	0.77	0.64	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	173.08	0.71	0.95	0.95	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	98.14	0.75	0.66	0.28	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	76.56	0.60	1.20	0.30	0.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	230.42	1.74	0.46	0.00	0.55	0.18
gall bladder, adult	10198-103E9	406.57	6.28	10.38	0.48	6.52	3.14
gamma delta positive T cells, donor1	11937-126A2	221.72	1.61	1.07	0.00	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	221.85	2.24	1.87	0.37	1.12	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	138.56	2.11	2.96	0.21	1.48	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	43.33	0.19	0.39	0.39	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	71.98	0.33	0.66	1.15	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	51.25	0.92	0.92	1.83	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	11.65	0.46	0.69	0.00	0.00	0.69
giant cell carcinoma cell line:LU65	10487-107B1	117.61	0.92	1.15	0.23	0.11	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	125.12	0.70	0.42	0.84	0.28	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	115.23	0.50	1.25	1.25	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	201.39	0.74	0.42	0.74	0.32	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	190.01	0.70	0.56	0.28	0.84	0.00
glioblastoma cell line:T98G	10485-107A8	124.28	0.44	0.66	0.33	0.00	0.11
glioma cell line:GI-1	10413-106B8	243.97	1.76	1.46	0.29	1.46	1.46
globus pallidus - adult, donor10196	10175-103C4	47.38	0.00	0.73	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	115.46	0.98	1.22	0.49	0.73	0.24
globus pallidus, adult, donor10258	10367-105F7	28.75	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	82.07	0.53	0.53	0.00	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	584.87	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	174.85	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	104.53	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	253.76	4.80	1.92	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	205.22	1.84	0.92	0.00	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	188.39	1.83	1.37	0.00	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	186.14	3.22	0.64	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	104.92	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	146.09	2.74	1.37	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	68.42	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	87.64	0.57	1.72	0.57	0.00	0.29
heart - mitral valve, adult	10205-103F7	189.84	2.69	2.09	0.90	1.49	1.20
heart - pulmonic valve, adult	10206-103F8	320.83	4.71	2.35	0.52	2.61	2.35
heart - tricuspid valve, adult	10207-103F9	290.59	6.66	5.83	0.00	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	137.13	1.63	2.24	0.20	0.61	0.41
heart, adult, diseased, donor1	10051-101G6	146.06	1.28	2.13	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	163.28	1.84	0.23	0.46	0.23	0.00
heart, fetal, pool1	10046-101G1	386.18	1.95	1.95	0.72	0.92	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	437.18	2.16	2.16	0.62	0.62	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	54.70	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	151.27	1.44	1.88	0.55	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	159.73	1.46	3.28	0.36	0.61	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	163.30	0.81	2.02	0.71	0.71	0.51
hepatoma cell line:Li-7	10484-107A7	208.31	1.22	1.33	0.56	1.11	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	129.44	0.40	0.20	0.10	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	49.21	0.95	1.89	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	65.11	0.41	1.02	0.20	0.00	0.41
hippocampus, adult, donor10258	10374-105G5	50.29	0.00	1.49	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	41.94	0.35	1.41	0.70	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	107.42	4.27	1.83	0.00	3.05	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	158.07	2.75	2.75	0.20	1.77	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	152.08	2.54	5.08	0.25	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	150.55	6.20	3.38	0.56	3.38	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	158.54	10.33	9.30	0.77	5.16	5.16
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	146.91	7.59	4.93	0.38	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	75.32	6.13	1.46	0.29	2.04	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	100.82	7.11	3.88	0.86	1.51	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	93.01	4.59	2.09	0.42	1.67	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	96.14	2.60	0.95	0.71	1.66	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	127.29	5.63	4.82	0.80	2.57	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	94.94	1.35	1.35	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	142.24	5.01	3.29	0.47	1.56	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	130.68	1.97	5.40	0.49	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	81.17	6.98	2.62	0.00	1.75	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	198.93	10.50	7.64	0.57	5.35	4.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	182.28	11.77	3.49	0.44	3.05	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	153.43	6.50	2.50	0.50	5.00	5.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	147.32	8.67	4.52	1.70	3.96	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	133.23	5.46	2.73	0.45	2.27	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	108.07	7.52	2.82	1.57	2.82	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	123.62	5.55	3.76	0.16	2.78	3.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	132.38	6.68	4.06	0.58	2.90	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	124.95	8.07	2.99	0.30	2.09	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	169.23	7.02	4.25	0.74	2.96	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	170.03	5.14	3.71	0.29	3.99	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	149.44	7.76	2.45	1.22	4.90	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	188.01	11.27	9.51	0.70	3.87	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	159.95	8.55	5.38	1.27	4.43	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	175.82	12.71	8.17	0.61	3.63	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	94.63	3.62	3.62	1.03	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	75.71	2.66	3.98	0.00	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	62.34	2.31	1.28	1.03	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	163.87	5.37	4.35	1.28	2.81	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	108.28	3.03	6.06	0.76	3.79	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	151.23	4.37	7.73	0.00	1.68	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	186.44	7.00	5.55	0.24	3.86	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	154.64	4.46	4.01	0.00	2.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	162.44	7.80	3.41	1.46	1.95	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	183.68	11.00	6.11	0.31	3.97	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	3.25	0.00	0.00	32.53	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	120.13	8.60	6.29	0.00	6.29	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	105.63	8.21	5.47	0.55	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	82.87	2.17	3.98	0.36	2.17	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	81.85	4.27	3.56	0.71	1.42	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	112.18	3.58	4.77	0.00	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	174.83	6.77	7.18	0.54	4.33	3.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	118.53	4.85	2.42	0.54	1.89	1.35
immature langerhans cells, donor1	11904-125F5	146.01	1.94	0.24	0.00	0.48	0.24
immature langerhans cells, donor2	11905-125F6	177.44	2.38	1.58	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	92.55	0.28	1.04	0.28	0.09	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	60.80	1.95	0.98	0.00	0.65	0.65
kidney, adult, pool1	10017-101C8	192.44	1.10	2.10	1.20	0.90	0.30
kidney, fetal, pool1	10045-101F9	211.85	0.71	0.92	0.64	0.35	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	323.95	2.70	0.99	0.99	0.99	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	93.87	1.80	1.66	0.28	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	133.22	0.18	0.00	0.55	0.18	0.18
left atrium, adult, donor1	10079-102A7	138.39	2.72	1.63	0.54	0.54	2.72
left ventricle, adult, donor1	10078-102A6	139.05	2.02	2.02	0.00	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	187.42	0.55	0.55	0.27	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	302.49	16.17	12.57	2.87	8.26	1.44
leiomyoma cell line:15242A	10570-108B3	323.91	14.67	9.24	3.26	4.35	1.63
leiomyoma cell line:15425	10571-108B4	360.58	15.30	17.24	3.89	3.64	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	292.07	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	224.79	11.50	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	331.03	1.53	1.77	0.35	0.47	0.71
liposarcoma cell line:KMLS-1	10782-110G8	144.49	0.94	1.87	0.47	0.47	0.78
liposarcoma cell line:SW 872	10726-110A6	229.42	0.97	1.34	0.24	0.49	0.49
liver, adult, pool1	10018-101C9	122.84	1.30	1.13	0.16	1.46	1.46
liver, fetal, pool1	10086-102B5	101.60	1.88	2.82	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	95.37	0.58	0.44	0.29	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	74.00	0.92	1.66	0.92	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	35.83	0.85	0.28	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	76.97	3.79	6.73	1.68	2.94	0.84
lung adenocarcinoma cell line:A549	10499-107C4	95.63	0.14	0.14	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	155.12	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	261.66	4.22	1.45	1.45	0.66	0.40
lung, adult, pool1	10019-101D1	456.92	11.10	3.19	4.49	6.73	4.25
lung, fetal, donor1	10068-101I5	524.01	2.00	5.71	4.28	1.43	2.85
lung, right lower lobe, adult, donor1	10075-102A3	316.17	8.25	13.75	9.16	9.62	6.42
lymph node, adult, donor1	10077-102A5	338.45	9.47	10.89	1.42	1.42	3.79
lymphangiectasia cell line:DS-1	10727-110A7	53.26	0.22	1.32	0.22	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1.96	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	94.29	1.70	0.85	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	86.58	1.78	0.00	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	111.65	1.25	0.00	1.04	0.21	0.42
mature adipocyte, donor3	12233-129G1	68.75	1.19	0.24	0.24	0.00	0.24
mature adipocyte, donor4	12234-129G2	49.75	0.53	0.53	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	42.65	0.24	0.00	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	66.55	1.13	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	91.77	1.10	1.66	0.37	1.10	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	54.01	0.64	0.00	0.32	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	35.40	1.71	0.85	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	70.54	2.03	4.22	0.84	0.68	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	95.93	1.06	2.33	0.42	0.00	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	55.99	0.00	0.72	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	68.14	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	93.81	0.62	1.39	0.31	0.62	0.15
medulla oblongata, adult, pool1	10038-101F2	141.38	0.57	0.98	0.49	0.16	0.16
medulla oblongata, newborn, donor10223	10361-105F1	84.02	2.78	1.04	1.04	1.04	0.35
medulloblastoma cell line:D283 Med	10838-111E1	93.88	1.11	0.89	0.44	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	153.33	0.98	0.49	0.24	0.12	0.37
melanoma cell line:COLO 679	10514-107E1	119.45	3.88	2.16	0.86	1.58	1.15
melanoma cell line:G-361	10465-106H6	141.43	5.43	4.07	0.54	4.89	2.44
meningioma cell line:HKBMM	10691-109F7	224.50	6.33	3.80	2.35	2.89	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	4.93	0.00	0.26	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	350.29	2.76	3.68	1.69	1.84	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	345.38	3.09	4.73	2.36	3.09	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	309.75	2.90	11.18	1.66	1.66	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	279.12	2.81	4.50	1.69	1.55	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	266.90	2.50	4.24	2.31	3.27	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	308.17	4.86	5.55	0.00	4.16	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	117.23	1.72	1.37	0.34	2.57	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	310.20	5.29	4.72	3.34	3.45	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	231.19	1.59	2.25	1.99	0.80	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	207.56	2.16	2.30	1.35	1.62	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	274.14	1.85	2.99	1.14	1.71	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	167.31	2.31	1.32	0.00	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	343.72	2.35	2.77	0.83	1.80	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	268.44	2.79	1.40	1.05	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	246.84	3.06	2.45	1.84	1.63	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	312.37	8.27	8.27	1.44	2.52	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	273.31	2.07	3.00	0.83	1.66	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	264.47	7.52	5.70	2.28	3.19	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	233.69	3.36	4.20	0.42	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	249.26	3.29	3.29	0.60	2.24	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	256.55	1.93	2.98	1.31	1.49	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	244.09	4.42	3.68	0.37	1.10	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	364.56	8.30	10.02	2.86	2.58	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	237.03	5.47	4.63	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	363.97	6.39	2.28	0.91	4.57	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	383.16	4.09	4.86	1.28	1.53	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	416.98	5.50	5.76	3.40	4.19	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	450.73	7.09	5.55	2.46	4.01	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	387.63	6.83	8.00	2.12	4.47	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	449.81	5.42	5.42	1.02	3.72	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	426.77	7.07	3.93	5.50	2.36	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	360.51	9.27	6.95	1.39	1.85	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	434.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	460.60	7.21	4.61	2.31	5.19	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	425.90	3.79	6.25	4.02	3.12	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	444.89	9.37	4.81	3.61	3.61	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	610.86	13.20	1.47	2.93	2.93	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	378.96	7.38	8.73	2.35	3.69	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	387.27	5.32	4.91	1.23	4.09	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	364.27	6.01	7.30	3.87	3.44	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	298.05	2.73	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	247.92	15.49	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	286.79	8.12	4.55	2.27	3.57	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	267.72	2.91	5.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	295.33	9.06	7.46	1.60	2.13	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	261.69	6.54	11.45	2.45	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	302.81	8.16	9.33	3.89	1.55	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	237.16	10.49	8.39	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	239.43	14.90	7.95	1.99	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	305.10	4.77	4.77	0.00	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	273.95	7.12	7.12	4.74	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	289.99	3.66	4.87	2.44	6.09	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	432.84	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	254.62	5.07	5.70	1.27	0.63	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	156.93	4.48	2.41	0.69	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	152.59	4.30	8.60	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	223.54	7.98	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	241.07	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	201.70	3.26	3.26	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	196.23	3.97	3.97	1.59	0.79	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	194.54	2.95	4.13	1.18	2.95	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	186.71	4.68	3.43	2.18	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	225.90	5.35	4.01	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	224.71	2.37	1.18	8.28	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	174.62	5.14	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	216.16	2.07	6.88	1.38	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	95.00	0.99	3.46	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	88.60	2.24	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	66.79	1.91	1.91	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	61.66	0.81	1.21	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	61.06	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	60.82	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	66.15	1.21	1.21	0.00	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	9.04	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	65.89	1.65	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	84.33	0.79	0.40	1.19	0.60	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	129.80	1.30	2.60	0.00	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	169.09	2.04	3.06	3.06	2.04	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	437.15	3.09	0.77	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	449.80	2.60	2.36	1.42	0.94	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	228.89	0.70	0.46	0.70	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	495.74	4.27	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	358.91	4.42	1.54	1.23	2.47	1.03
mesothelioma cell line:Mero-25	10850-111F4	235.80	3.63	2.72	0.45	0.91	0.45
mesothelioma cell line:Mero-41	10851-111F5	701.64	4.16	8.31	1.47	2.20	0.98
mesothelioma cell line:Mero-48a	10852-111F6	520.81	5.98	6.64	1.55	1.77	0.66
mesothelioma cell line:Mero-82	10853-111F7	411.03	5.78	3.42	1.84	1.84	1.05
mesothelioma cell line:Mero-83	10854-111F8	269.63	3.57	4.43	0.68	3.57	2.38
mesothelioma cell line:Mero-84	10855-111F9	202.98	0.76	2.02	0.76	0.76	0.51
mesothelioma cell line:Mero-95	10856-111G1	339.76	6.83	4.97	1.24	2.28	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	165.15	1.49	1.82	0.99	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	315.83	2.17	3.62	0.72	1.45	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	281.69	2.73	2.73	0.68	1.02	0.34
mesothelioma cell line:NCI-H28	10845-111E8	98.73	3.05	1.78	0.00	0.51	0.00
mesothelioma cell line:No36	10857-111G2	186.26	0.65	2.94	0.33	1.30	0.65
mesothelioma cell line:ONE58	10858-111G3	336.52	2.71	3.25	0.81	1.35	1.35
migratory langerhans cells, donor1	11901-125F2	730.46	8.64	7.29	0.77	2.30	3.26
migratory langerhans cells, donor2	11902-125F3	600.81	5.37	4.52	0.49	2.08	2.44
migratory langerhans cells, donor3	11903-125F4	479.93	3.41	2.87	0.18	1.62	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	201.11	5.88	3.92	0.98	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	117.41	2.12	2.33	0.00	1.70	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	111.95	1.15	0.23	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	105.23	1.90	0.57	0.00	0.95	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	321.72	2.59	2.77	1.48	0.92	0.74
myeloma cell line:PCM6	10474-106I6	142.91	0.99	0.20	0.00	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	295.24	2.03	2.03	0.00	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	258.12	1.96	1.96	0.59	1.37	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	128.03	0.33	0.67	0.56	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	107.52	0.59	0.96	0.22	0.74	0.07
nasal epithelial cells, donor2	12227-129F4	242.32	1.10	1.10	1.66	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	96.17	0.23	0.46	0.23	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	204.48	1.12	0.56	0.75	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	56.10	0.63	0.84	0.42	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	86.09	0.56	0.56	0.37	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	102.01	0.95	0.71	0.71	1.19	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	76.50	0.95	1.58	0.16	0.95	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	78.09	0.60	0.81	0.40	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	106.81	0.00	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	536.59	3.46	1.06	0.80	1.60	1.86
neutrophil PMN, donor1	12133-128D9	2305.60	0.00	0.00	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	451.54	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	625.06	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	71.37	0.17	0.34	0.51	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	271.23	4.81	4.17	0.32	1.92	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	280.37	6.31	5.52	0.79	1.31	1.05
nucleus accumbens, adult, pool1	10037-101F1	79.40	0.47	0.47	0.09	0.28	0.00
occipital cortex - adult, donor10196	10172-103C1	144.23	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	127.20	1.88	2.95	0.54	1.61	2.15
occipital cortex, newborn, donor10223	10355-105E4	62.23	0.36	0.73	1.09	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	77.41	4.46	6.30	0.52	2.62	0.79
occipital lobe, fetal, donor1	10073-102A1	99.55	2.15	3.43	0.00	1.29	0.00
occipital pole, adult, pool1	10036-101E9	155.95	0.63	0.87	0.24	0.24	0.00
olfactory region, adult	10195-103E6	63.81	1.91	1.15	0.19	0.19	0.19
optic nerve, donor1	10277-104E7	118.06	6.00	2.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	137.03	2.96	0.80	0.23	0.68	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	52.89	0.27	0.55	0.14	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	107.52	3.05	2.20	0.51	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	142.31	1.04	1.62	0.81	0.58	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	303.37	4.41	1.47	0.00	2.35	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	172.85	0.93	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	88.85	0.21	0.64	0.00	0.64	0.00
ovary, adult, pool1	10020-101D2	412.74	6.55	4.37	0.96	3.41	2.71
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	179.84	0.92	0.73	0.18	0.55	0.73
pancreas, adult, donor1	10049-101G4	65.84	0.00	2.82	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	43.33	1.40	0.00	0.00	0.28	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	155.19	2.21	4.94	0.17	0.68	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	191.41	2.48	0.66	0.83	0.83	0.17
paracentral gyrus, adult, pool1	10035-101E8	122.46	0.73	0.18	0.37	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	35.97	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	56.43	2.82	1.88	0.00	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	100.05	2.00	2.85	0.29	0.29	1.14
parietal lobe, adult, pool1	10034-101E7	114.56	0.79	0.97	0.26	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	89.22	0.97	3.88	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	63.56	1.12	1.50	0.37	0.37	0.37
parotid gland, adult	10199-103F1	101.13	1.23	1.23	0.00	0.62	0.62
penis, adult	10200-103F2	358.25	9.13	5.91	0.54	3.76	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	95.39	0.93	0.93	0.74	0.56	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	77.66	0.58	0.58	0.15	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	83.85	0.65	1.29	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	55.67	0.59	0.59	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	44.52	1.88	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	68.80	1.01	1.01	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	53.68	0.00	1.04	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	12.77	0.00	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	228.01	2.26	2.26	0.97	0.65	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	68.73	1.19	0.93	0.79	0.40	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	109.57	1.25	0.78	0.31	1.09	0.00
pons, adult, pool1	10033-101E6	134.44	1.29	0.60	0.17	0.26	0.26
postcentral gyrus, adult, pool1	10032-101E5	123.09	0.61	0.87	0.44	0.61	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	736.17	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	148.72	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	106.92	0.58	0.73	0.15	0.29	0.29
prostate cancer cell line:PC-3	10439-106E7	730.73	3.81	2.36	38.66	2.36	0.91
prostate, adult, pool1	10022-101D4	335.56	4.90	2.81	0.54	2.27	1.63
putamen, adult, donor10196	10176-103C5	53.35	1.18	2.12	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	31.37	1.96	0.00	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	63.38	1.09	1.09	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	30.44	0.00	0.00	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	46.48	3.00	3.75	0.75	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	153.03	2.62	0.00	0.00	1.45	0.29
rectum, fetal, donor1	10067-101I4	333.84	4.17	4.17	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	118.72	0.85	1.27	0.00	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	32.72	0.00	1.24	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	179.32	1.09	1.39	0.60	0.60	0.20
retinoblastoma cell line:Y79	10475-106I7	8.05	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	16.84	0.25	0.00	0.37	0.12	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	214.84	0.84	0.28	1.12	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	556.27	1.52	1.52	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	296.04	6.64	4.21	1.46	3.56	0.97
salivary acinar cells, donor2	11772-123I8	175.41	4.41	3.72	0.28	2.48	1.79
salivary acinar cells, donor3	11773-123I9	170.81	2.65	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	107.53	0.57	1.14	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	164.24	2.19	1.01	0.25	0.93	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	135.18	1.53	0.47	0.00	0.35	0.47
seminal vesicle, adult	10201-103F3	187.29	7.94	5.29	0.53	2.12	4.76
serous adenocarcinoma cell line:JHOS-2	10639-108I9	146.73	1.70	2.67	0.24	0.24	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	93.10	0.75	1.26	0.00	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	186.66	1.00	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	176.90	0.54	1.07	0.81	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	63.55	0.66	0.44	0.22	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	64.51	0.65	0.39	0.13	0.52	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	58.87	2.13	2.13	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	206.65	2.64	1.08	0.84	2.28	1.20
skeletal muscle, fetal, donor1	10066-101I3	296.48	4.02	11.06	1.01	2.01	4.02
skin, adult, donor1	10074-102A2	128.92	0.00	6.79	0.00	0.00	13.57
skin, fetal, donor1	10065-101I2	94.68	1.26	3.16	0.00	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	6.34	0.33	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	76.91	2.21	0.63	0.00	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	71.12	1.73	0.39	1.54	0.96	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	36.10	0.33	0.16	0.16	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	59.03	0.97	0.48	0.97	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	66.90	0.22	0.22	0.44	0.87	0.00
small intestine, adult, pool1	10024-101D6	242.47	7.17	3.22	0.36	2.15	1.43
small intestine, fetal, donor1	10064-101I1	187.22	2.70	4.91	0.00	0.74	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.72	0.00	0.51	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	480.98	4.65	7.24	0.78	2.58	1.55
somatostatinoma cell line:QGP-1	10781-110G7	75.58	0.80	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	68.82	0.46	1.15	0.46	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	98.17	0.79	0.79	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	25.60	0.00	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	112.82	3.05	3.66	0.00	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	64.75	1.38	0.46	0.92	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	607.13	4.03	2.69	2.69	0.90	0.90
spleen, adult, pool1	10025-101D7	411.13	4.30	2.97	1.87	2.53	3.41
spleen, fetal, pool1	10044-101F8	372.72	2.78	2.46	1.03	1.35	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	59.21	0.21	0.52	0.21	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	125.89	0.76	0.57	0.57	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	106.93	2.80	2.80	0.35	2.10	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	95.78	2.74	0.78	0.00	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	115.71	0.56	0.45	0.11	0.23	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.05	0.42	1.69	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	204.34	1.69	0.85	0.00	0.42	0.85
stomach, fetal, donor1	10062-101H8	279.81	0.00	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	103.68	0.57	2.85	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	85.16	1.87	1.66	1.04	0.62	0.62
substantia nigra, adult, donor10258	10371-105G2	50.17	0.00	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	87.62	1.41	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	107.75	1.38	0.46	0.92	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	106.90	0.76	0.68	0.34	0.34	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	94.73	2.14	6.41	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	110.32	1.76	3.08	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	425.90	3.49	7.33	1.75	3.49	1.75
tenocyte, donor2	11765-123I1	260.19	2.29	3.05	0.00	1.14	0.00
tenocyte, donor3	11768-123I4	528.57	2.97	7.41	10.75	3.71	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	197.15	1.53	2.38	1.19	0.51	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	131.49	1.70	1.08	0.31	1.23	1.23
teratocarcinoma cell line:PA-1	10807-111A6	293.68	1.24	1.39	1.55	1.55	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	210.22	7.11	1.65	0.51	1.90	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	198.92	3.03	2.27	0.76	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	169.59	2.29	0.98	1.96	1.53	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	139.08	2.61	2.28	0.65	0.98	0.65
testis, adult, pool1	10026-101D8	433.14	7.84	5.58	1.07	5.37	8.16
testis, adult, pool2	10096-102C6	304.93	5.41	7.67	0.45	2.26	1.80
thalamus - adult, donor10196	10168-103B6	69.55	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	75.17	1.25	0.94	0.16	0.78	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	72.36	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	43.97	0.82	0.66	0.16	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	31.64	1.73	1.15	0.00	1.73	0.58
throat, adult	10209-103G2	125.33	2.50	2.75	0.00	2.00	0.00
throat, fetal, donor1	10061-101H7	113.96	0.61	1.83	0.61	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	19.67	0.00	0.20	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	193.16	3.78	0.89	1.19	2.09	1.29
thymus, fetal, pool1	10043-101F7	228.90	2.08	2.29	1.35	1.66	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	261.00	3.32	3.19	1.33	1.46	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	118.88	1.12	1.26	0.28	0.56	0.70
thyroid, adult, pool1	10028-101E1	164.23	1.59	1.12	0.75	1.49	0.37
thyroid, fetal, donor1	10060-101H6	131.04	1.58	1.32	0.26	1.85	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	187.86	3.08	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	119.54	3.49	3.02	0.23	2.56	0.70
tongue, fetal, donor1	10059-101H5	131.63	1.18	3.15	0.39	1.18	1.18
tonsil, adult, pool1	10047-101G2	248.13	0.70	1.80	0.80	0.70	0.00
trachea, adult, pool1	10029-101E2	304.62	2.29	2.62	0.82	1.15	1.39
trachea, fetal, donor1	10058-101H4	164.26	3.08	4.62	2.69	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	576.76	5.67	4.96	2.83	2.13	3.19
transitional-cell carcinoma cell line:5637	10418-106C4	154.00	1.11	0.81	0.30	0.81	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	157.94	4.86	4.07	0.63	1.41	1.10
tridermal teratoma cell line:HGRT	10694-109G1	321.53	1.90	0.00	3.81	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	114.53	0.68	0.76	0.17	0.68	0.25
umbilical cord, fetal, donor1	10057-101H3	252.47	2.09	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	819.53	4.10	4.78	1.71	3.41	1.37
uterus, fetal, donor1	10055-101H1	372.68	3.07	6.14	0.51	2.05	0.51
vagina, adult	10204-103F6	229.40	3.88	1.29	2.58	1.94	0.65
vein, adult	10191-103E2	314.33	5.92	7.45	1.32	2.41	3.95
xeroderma pigentosum b cell line:XPL 17	10563-108A5	88.92	0.53	1.60	0.27	0.00	0.27